Form 10-Q - Quarterly report [Sections 13 or 15(d)]

 

 

 

U. S. SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2024

 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to _________

 

Commission File No. 001-37370

 

MY SIZE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware		51-0394637
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer I.D. No.)

 

HaNegev 4, POB 1026, Airport City, Israel, 7010000

(Address of principal executive offices)

 

[phone]

Registrant’s telephone number, including area code:

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value per share		MYSZ		Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: as of August 1, 2024, 1,067,131 shares of common stock, par value $0.001 per share were issued and outstanding.

 

 

 

 

MY SIZE, INC.

INDEX TO QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED JUNE 30, 2024

 

TABLE OF CONTENTS

 

		PAGE
PART I - FINANCIAL INFORMATION		1
Item 1.	Condensed Consolidated Interim Financial Statements (Unaudited)	2
	Condensed Consolidated Interim Balance Sheets	3
	Condensed Consolidated Interim Statements of Comprehensive Loss	4
	Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity	5
	Condensed Consolidated Interim Statements of Cash Flows	7
	Notes to Condensed Consolidated Interim Financial Statements	8
Item 2.	Management’s Discussion & Analysis of Financial Condition and Results of Operations	16
Item 3.	Quantitative and Qualitative Disclosure About Market Risk	21
Item 4.	Controls and Procedures	21
PART II - OTHER INFORMATION		22
Item 1.	Legal Proceedings	22
Item 1A.	Risk Factors	22
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	24
Item 3.	Defaults Upon Senior Securities	24
Item 4.	Mine Safety Disclosures	24
Item 5	Other information	24
Item 6.	Exhibits	24

 

i

 

PART I

FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

My Size, Inc. and Subsidiaries

 

Condensed Consolidated

Interim

Financial Statements

As of June 30, 2024

(unaudited)

U.S. Dollars in Thousands

 

1

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Financial Statements as of June 30, 2024 (Unaudited)

Contents

 

	Page
Condensed Consolidated Interim Balance Sheets (Unaudited)	3
Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)	4
Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity (Unaudited)	5-6
Condensed Consolidated Interim Statements of Cash flows (Unaudited)	7
Notes to Condensed Consolidated Interim Financial Statements (Unaudited)	8-15

 

2

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Balance Sheets (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

		June 30,				December 31,
		2024				2023
Assets
Current Assets:
Cash and cash equivalents			3,201				2,187
Restricted cash			74				77
Short term deposit			-				22
Inventory			1,793				2,879
Account receivables			329				615
Other receivables and prepaid expenses			807				847
Total current assets			6,204				6,627
Long term deposits			7				7
Property and equipment, net			107				121
Operating right-of-use asset			32				351
Intangible assets			919				1,097
Goodwill			733				758
Investment in JV			-				24
Investment in marketable securities			10				6
Total non-current assets			1,808				2,364
Total assets			8,012				8,991
Liabilities and stockholders’ equity
Current liabilities:
Operating lease liability			17				158
Bank overdraft and short-term loans			423				158
Trade payables			896				2,154
Liabilities to Related parties			70				605
Other payables			703				803
Total current liabilities			2,109				3,878
Long-term loans			193				249
Operating lease liability			15				129
Total non-current liabilities			208				378
Total liabilities			2,317				4,256
COMMITMENTS AND CONTINGENCIES
Stockholders’ equity:
Stock Capital -
Common stock of $0.001 par value - Authorized: 250,000,000 shares; Issued and outstanding: 883,131(*) and 452,724(*) as of June 30, 2024 and December 31, 2023, respectively			1				1
Additional paid-in capital			68,425				65,386
Accumulated other comprehensive loss			(870	)			(771	)
Accumulated deficit			(61,861	)			(59,881	)
Total stockholders’ equity			5,695				4,735
Total liabilities and stockholders’ equity			8,012				8,991

 

(*)	Adjusted to give retroactive effect of 1:8 Reverse stock split, see note 8 (d)

 

The accompanying notes are an integral part of the condensed consolidated interim financial statements.

 

3

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

		Six-Months Ended June 30,								Three-Months Ended June 30,
		2024				2023				2024				2023
Revenues			4,963				2,010				1,979				1,290
Cost of revenues (*)			(2,783	)			(1,918	)			(995	)			(771	)
Gross profit			2,180				92				984				519
Operating expenses
Research and development			(263	)			(569	)			(131	)			(227	)
Sales and marketing			(1,933	)			(1,646	)			(831	)			(967	)
General and administrative			(1,932	)			(1,923	)			(899	)			(879	)
Total operating expenses			(4,128	)			(4,138	)			(1,861	)			(2,073	)
Operating loss			(1,948	)			(4,046	)			(877	)			(1,554	)
Financial income (expenses), net			(32	)			(100	)			(87	)			46
Equity loss of equity method investees***			-				(39	)			-				(5	)
Loss before taxes			(1,980	)			(4,185	)			(964	)			(1,513	)
Taxes on income			-				240				-				222
Net loss			(1,980	)			(3,945	)			(964	)			(1,291	)
Other comprehensive income (loss):
Foreign currency translation differences			(99	)			(39	)			8				(24	)
Total comprehensive loss			(2,079	)			(3,984	)			(956	)			(1,315	)
Basic and diluted loss per share**			(3.06	)			(14.40	)			(1.28	)			(4.24	)
Basic and diluted weighted average number of shares outstanding**			647,321				273,845				755,600				305,519

 

(*)	During the six months ended June 30, 2023, the Company recorded an inventory write-down of $643 due to the fire that occurred in its warehouse).
(**)	Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d).

 

(***)

In March 2024, the Company closed a joint venture (the “JV”) in Brazil with Santista Têxtil.

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

4

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

		Common stock								Additional paid-in				Accumulated other comprehensive				Accumulated				Total stockholders’
		Number**				Amount**				capital**				loss				deficit				equity
Balance as of January 1, 2024			452,724				1				65,386				(771	)			(59,881	)			4,735
Stock-based compensation related to options granted to employees and consultants			80,000				*				217				-				-				217
Issuance of shares post Business Combination			4,360				*				3				-				-				3
Effect of reverse stock split			74,683				*				-				-				-				-
Issuance of shares, net of issuance cost of $442 (***)			79,000				*				2,819				-				-				2,819
Exercise of shares in abeyance			192,364				*				-				-				-				-
Total comprehensive loss			-				-				-				(99	)			(1,980	)			(2,079	)
Balance as of June 30, 2024			883,131				1				68,425				(870	)			(61,861	)			5,695

 

(*)	Represents an amount less than $1.
(**)	Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d).
(***)	See note 8 (f).

 

		Common stock								Additional paid-in				Accumulated other comprehensive				Accumulated				Total stockholders’
		Number**				Amount**				Capital**				loss				deficit				equity
Balance as of January 1, 2023			183,015				1				58,673				(637	)			(53,501	)			4,536
Stock-based compensation related to options granted to employees and consultants			(1,000	)			*				222				-				-				222
Issuance of shares, net of issuance cost of $341(**)			20,250				*				2,658				-				-				2,658
Exercise of warrants and prefunded warrants			102,583				*				1				-				-				1
Total comprehensive loss			-				-				-				(39	)			(3,945	)			(3,984	)
Balance as of June 30, 2023			304,848				1				61,554				(676	)			(57,446	)			3,433

 

(*)	Represents an amount less than $1
(**)	Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d).

 

		Common stock								Additional paid-in				Accumulated other comprehensive				Accumulated				Total stockholders’
		Number**				Amount**				Capital**				loss				deficit				equity
Balance as of April 1, 2024			641,459				1				65,527				(878	)			(60,897	)			3,753
Stock-based compensation related to options granted to employees and consultants			-								79				-				-				79
Effect of reverse stock split			74,683				*				-				-				-				-
Issuance of shares, net of issuance cost of $442 (***)			79,000				*				2,819				-				-				2,819
Exercise of warrants and prefunded warrants			87,989				*				-				-				-				-
Total comprehensive loss			-				-				-				8				(964	)			(956	)
Balance as of June 30, 2024			883,131				1				68,425				(870	)			(61,861	)			5,695

 

(*)	Represents an amount less than $1
(**)	Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d).
(***)	See note 8 (f).

 

5

 

		Common stock								Additional paid-in				Accumulated other comprehensive				Accumulated				Total stockholders’
		Number**				Amount**				Capital**				loss				deficit				equity
Balance as of April 1, 2023			305,848				1				61,468				(652	)			(56,155	)			4,662
Stock-based compensation related to options granted to employees and consultants			(1,000	)			*				86				-				-				86
Total comprehensive loss			-				-				-				(24	)			(1,291	)			(1,315	)
Balance as of June 30, 2023			304,848				1				61,554				(676	)			(57,446	)			3,433

 

(*)	Represents an amount less than $1
(**)	Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d).

 

		Common stock								Additional paid-in				Accumulated other comprehensive				Accumulated				Total stockholders’
		Number**				Amount**				capital**				loss				deficit				equity
Balance as of December 31, 2022			183,015				1				58,673				(637	)			(53,501	)			4,536
Stock-based compensation related to options and restricted shares granted to employees and consultants			(1,000	)			(*)				453				-				-				453
Issuance of shares, net of issuance cost of $959			54,000				(*)				6,258				-				-				6,258
Exercise of shares in abeyance			216,709				(*)				2				-				-				2
Total comprehensive loss			-				-				-				(134	)			(6,380	)			(6,514	)
Balance as of December 31, 2023			452,724				1				65,386				(771	)			(59,881	)			4,735

 

(*)	Represents an amount less than $1.

 

(**)	Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d).

 

6

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

U.S. dollars in thousands

 

		Six-Months Ended June 30,
		2024				2023
Cash flows from operating activities:
Net loss			(1,980	)			(3,945	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation			16				16
Change in operating lease right-of-use asset			138				88
Amortization of intangible assets			76				151
Change in liabilities to related parties			(525	)			(76	)
Interest of long-term liabilities			41				11
Interest paid			(37	)			(11	)
Revaluation of investment in marketable securities			(4	)			23
Change in Investment in JV			-				39
Stock based compensation			217				222
Change in inventory			1,080				(95	)
Change in deferred tax liabilities			-				(36	)
Change in account receivable			282				1,119
Changes in operating lease liabilities			(97	)			(68	)
Change in other receivables and prepaid expenses			38				(205	)
Change in trade payables			(1,212	)			(888	)
Change in other payables			(109	)			15
Net cash used in operating activities			(2,076	)			(3,640	)
Cash flows from investing activities:
Proceeds from investment in JV			38				-
Proceeds from short-term deposits			22				-
Net cash used in investing activities			60				-
Cash flows from financing activities:
Proceeds from issuance of shares, net of issuance costs			2,819				2,658
Loans received			500				-
Repayment of loans			(358	)			(62	)
Net cash provided by financing activities			2,961				2,596
Effect of exchange rate fluctuations on cash and cash equivalents			66				(69	)
Increase (decrease) in cash, cash equivalents and restricted cash (*)			1,011				(1,113	)
Cash, cash equivalents and restricted cash at the beginning of the period			2,264				2,363
Cash, cash equivalents and restricted cash at the end of the period			3,275				1,250
Non cash activities:
Change in operating lease right-of-use asset and liability			181				-

 

(*)	$1,014 relates to change in cash and cash equivalents and, $(3) to change in restricted cash for the six months ended June 30, 2024.

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.

 

7

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 1 - General

 

	a.	My Size, Inc. (the “Company”) is developing unique measurement technologies based on algorithms with applications in a variety of areas, including the apparel e-commerce market, the courier services market and the Do It Yourself (“DIY”) smartphone and tablet apps market. The technology is driven by proprietary algorithms, which are able to calculate and record measurements in a variety of novel ways.   Following the acquisition of Naiz Fit Bespoke Technologies, S.L (“Naiz”) in October 2022, the Company expanded its offering outreach and customer base.   Following the acquisition of Orgad International Marketing Ltd. (“Orgad”) in February 2022, the Company also operates an omnichannel e-commerce platform.   The Company has six subsidiaries, My Size Israel 2014 Ltd. (“My Size Israel”), Topspin Medical (Israel) Ltd., Orgad and Rotrade Ltd., all of which are incorporated in Israel, My Size LLC, which is incorporated in the Russian Federation and Naiz, a limited liability company incorporated under the laws of Spain. References to the Company include the subsidiaries unless the context indicates otherwise.   My Size, Inc., was incorporated and commenced operations in September 1999, as Topspin Medical Inc. (“Topspin”), a private company registered in the State of Delaware. In December 2013, the Company changed its name to Knowledgetree Ventures Inc. Subsequently, in February 2014, the Company changed its name to My Size, Inc. Topspin was engaged, through its Israeli subsidiary, in research and development in the field of cardiology and urology.   On July 25, 2016, the Company’s common stock began publicly trading on the Nasdaq Capital Market under the symbol “MYSZ”.   From September 1, 2005 to March 27, 2024, the Company’s common stock was traded on the Tel Aviv Stock Exchange.
	b.	Since inception, the Company has incurred significant losses and negative cash flows from operations and had an accumulated deficit of $61,861. The Company has financed its operations mainly through fundraising from various investors.   The Company’s management expects that the Company will continue to generate losses and negative cash flows from operations for the foreseeable future. Based on the projected cash flows and cash balances as of June 30, 2024, management is of the opinion that its existing cash will not be sufficient to fund operations for a period of more than 12 months. As a result, there is substantial doubt about the Company’s ability to continue as a going concern.   Management’s plans include the continued commercialization of the Company’s products and securing sufficient financing through the sale of additional equity securities, debt or capital inflows from strategic partnerships. Additional funds may not be available when the Company needs them, on terms that are acceptable to it, or at all. If the Company is unsuccessful in commercializing its products and securing sufficient financing, it may need to cease operations.   The financial statements include no adjustments for measurement or presentation of assets and liabilities, which may be required should the Company fail to operate as a going concern.
	c.	In October 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel’s border with the Gaza Strip and in other areas within the State of Israel. These attacks resulted in thousands of deaths and injuries, and Hamas additionally kidnapped many Israeli civilians and soldiers. Following the attack, Israel’s security cabinet declared war against Hamas and commenced a military campaign against Hamas and other terrorist organizations in parallel to their continued rocket and terror attacks. In addition, since the commencement of these events, there have been continued hostilities along Israel’s northern border with Lebanon (with the Hezbollah terror organization) and southern border (with the Houthi movement in Yemen). It is possible that hostilities with Hezbollah in Lebanon will escalate, and that other terrorist organizations, including Palestinian military organizations in the West Bank as well as other hostile countries will join the hostilities. In addition, Iran recently launched a direct attack on Israel involving hundreds of drones and missiles and has threatened to continue to attack Israel and is widely believed to be developing nuclear weapons. Iran is also believed to have a strong influence among extremist groups in the region, such as Hamas in Gaza, Hezbollah in Lebanon, the Houthi movement in Yemen and various rebel militia groups in Syria and Iraq. Such clashes may escalate in the future into a greater regional conflict.
		The war with Hamas has had an immaterial effect on its operations and financial results so far. This is attributable to its global footprint and the offices in Spain, which has become a hub for the Company’s sizing solutions business. The majority of Orgad’s inventory utilizes fulfillment by Amazon rather than fulfilling directly. Inventory is now maintained and orders are shipped from regional Amazon warehouses, thereby reducing exposure to inventory risk and contributing to operating efficiencies.   On February 24, 2022, Russia invaded Ukraine. The outbreak of hostilities between the two countries could result in more widespread conflict and could have a severe adverse effect on the region. Following Russia’s actions, various countries, issued broad-ranging economic sanctions against Russia. Such sanctions included, among other things, a prohibition on doing business with certain Russian companies, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications (SWIFT) electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions.   The Company shut down its operation in Russia and expected to close down its subsidiary, My Size LLC, but due to technical reasons it is expected to occur in the near future; therefore, the impact from the current situation is very limited.

 

8

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 2 - Significant Accounting Policies

 

	a.	Unaudited condensed consolidated financial statements:
		The accompanying unaudited condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”). The unaudited condensed consolidated financial statements are comprised of the financial statements of the Company. In management’s opinion, the interim financial data presented includes all adjustments necessary for a fair presentation. All intercompany accounts and transactions have been eliminated. Operating results for the six months ended June 30, 2024 are not necessarily indicative of the results that may be expected for any future period or for the year ending December 31, 2024.
		These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2023.
	b.	Significant Accounting Policies:
		The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the latest annual financial statements.
	c.	Critical accounting estimates:
		ASC 350 requires goodwill to be tested for impairment at the reporting unit level at least annually, or between annual tests under certain circumstances, and written down when impaired. Goodwill is tested for impairment by comparing the fair value of the reporting unit with it carrying value.
		During the first and second quarters of 2024, there was no more likely than not indication of impairment; therefore, no further impairment testing was required.
	d.	Recent adopted accounting pronouncements:
		In June 2022, the FASB issued ASC 2022-03 “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. The ASU clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring its fair value. The ASU also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The ASU also introduces new disclosure requirements for equity securities subject to contractual sale restrictions. The ASU do not have a material impact on the Company consolidated financial statements.
		In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). This ASU reduces the number of accounting models for convertible debt instruments and convertible preferred stock and amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves and amends the related earnings per share guidance. This standard became effective for the Company beginning on January 1, 2024. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company adopted this guidance effective January 1, 2024, and the adoption of this standard did not have a material impact on its consolidated financial statements.

 

Note 3 – Financial Instruments

 

The carrying amounts of cash and cash equivalents, restricted cash, accounts receivable, other receivables, trade payables and accounts payable approximate their fair value due to the short-term maturities of such instruments.

 

The Company holds share certificates in iMine Corporation (“iMine”), formerly known as Diamante Minerals, Inc., a publicly traded company on the OTCQB.

 

Due to sales restrictions on the sale of the iMine shares, the fair value of the shares was measured on the basis of the quoted market price for an otherwise identical unrestricted equity instrument of the same issuer that trades in a public market, adjusted to reflect the effect of the sales restrictions and is therefore, ranked as Level 2 assets.

 

 

June 30, 2024

Fair value hierarchy

Level 1

Level 2

Level 3

Financial assets

Investment in marketable securities (*)

-

10

-

 

9

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 3 - Financial Instruments (Cont.)

 

December 31, 2023

Fair value hierarchy

Level 1

Level 2

Level 3

Financial assets

Investment in marketable securities (*)

-

6

-

 

(*)	For the six and three-month periods ended June 30, 2024 and 2023, the Company recognized gain (loss) (based on quoted market prices with a discount due to security restrictions on iMine shares) of the marketable securities was $4, $(21), $(1) $and $(7), respectively.

 

Note 4 - Stock Based Compensation

 

The stock-based expense equity awards recognized in the financial statements for services received is related to Cost of Revenues, Research and Development, Sales and Marketing and General and Administrative expenses as shown in the following table:

 

		Six months ended June 30,								Three months ended June 30,
		2024				2023				2024				2023
Stock-based compensation expense – Cost of revenues			1				15				-				6
Stock-based compensation expense - Research and development			29				29				16				6
Stock-based compensation expense - Sales and marketing			24				55				8				15
Stock-based compensation expense - General and administrative			166				123				55				59
			220				222				79				86

 

10

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 4 - Stock Based Compensation (Cont.)

 

Stock Option Plan for Employees:

 

In March 2017, the Company adopted the My Size, Inc. 2017 Equity Incentive Plan (the “2017 Employee Plan”) pursuant to which the Company’s Board of Directors may grant stock options and other equity awards to officers and key employees. The total number of shares of common stock which may be granted to directors, officers, employees under this plan, is limited to 130,000 shares. Stock options can be granted with an exercise price equal to or less than the stock’s fair market value at the date of grant.

 

On December 27, 2023, the Company’s stockholders approved an increase in the shares available for issuance under the 2017 Equity Incentive Plan from 36,125 shares to 130,000 shares.

 

On February 14, 2024, the Compensation Committee of the Company granted restricted common stock awards under the Company’s 2017 Equity Incentive Plan to Ronen Luzon, Or Kles and Billy Pardo, pursuant to which they were issued 37,500 restricted shares, 18,750 restricted shares and 18,750 restricted shares, respectively. The restricted shares shall vest in three equal installments on January 1, 2025, January 1, 2026 and January 1, 2027, conditioned upon continuous employment with the Company and subject to accelerated vesting upon a change in control of the Company. On the same day, the Company granted a total of 10,000 restricted stock units (“RSUs”) to its directors that will vest on January 1, 2025 and five-years options to purchase up to 6,875 shares of common stock to other employees of the Company at an exercise price of $3.832 per share. The option vesting period is over three years in three equal portions from the vesting commencement date.

 

The fair value of each option award is estimated on the date of grant using the Binomial option-pricing model that used the weighted average assumptions in the following table. The risk free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant

 

		2024 Grants
Dividend yield			0	%
Expected volatility			86.22	%
Risk-free interest			4.3	%
Contractual term			2.0-2.8

 

During the six and three-month periods ended June 30, 2024, the Company granted options, restricted stock and RSUs to purchase 91,875 and 0 shares of common stock under the 2017 Employee Plan (as described above), respectively. No options were exercised and 4,000 options expired.

 

The total stock option compensation expense for employees during the six and three-month periods ended June 30, 2024 and 2023 was $146, $79, $162 and $44, respectively.

 

The total stock option compensation expense relating to the Orgad acquisition during the six and three-month periods ended June 30, 2024 and 2023 was $3, $0, $60 and $118, respectively.

 

Options issued to consultants:

 

In July 2023, the Company entered into a six month agreement (the “Consultant Agreement”) with a consultant (the “Consultant”) to provide services to the Company, including assisting the Company to promote, market and sell the Company’s technology to potential customers and make strategic introductions and inquiries with interested parties in the financial community. Pursuant to the Consultant Agreement and in partial consideration for such consulting services, the Company issued to the Consultant (i) 5,000 shares of restricted common stock of the Company, (ii) a warrant to purchase 12,500 shares of common stock at an exercise price of $4.00 per share and exercisable for a term of 36 months from the date of issuance, and (iii) a warrant to purchase 12,500 shares of common stock at an exercise price of $6.00 per share and exercisable for a term of 36 months from the date of issuance.

 

The issuance was approved by the Company’s board of directors in February 2024.

 

During the six and three-month periods ended June 30, 2024, the Company recorded $71 and $0, respectively, as stock-based equity awards with respect to the Consultant. No expenses were recorded in the fiscal year ended December 31, 2023 with respect to the Consultant.

 

11

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 5 - Contingencies and Commitments

 

	a.	On August 7, 2018, the Company commenced an action against North Empire LLC (“North Empire”) in the Supreme Court of the State of New York, County of New York for breach of a Securities Purchase Agreement (the “Agreement”) in which it is seeking damages in an amount to be determined at trial, but in no event less than $616. On August 2, 2018, North Empire filed a Summons with Notice against the Company, also in the same Court, in which they allege damages in an amount of $11,400 arising from an alleged breach of the Agreement. On September 6, 2018 North Empire filed a Notice of Discontinuance of the action it had filed on August 2, 2018. On September 27, 2018, North Empire filed an answer and asserted counterclaims in the action commenced by the Company against them, alleging that the Company failed to deliver stock certificates to North Empire causing damage to North Empire in the amount of $10,958. North Empire also filed a third-party complaint against the Company’s CEO and now former Chairman of the Board asserting similar claims against them in their individual capacities. On October 17, 2018, the Company filed a reply to North Empire’s counterclaims. On November 15, 2018, the Company’s CEO and now former Chairman of the Board filed a motion to dismiss North Empire’s third-party complaint. On January 6, 2020, the Court granted the motion and dismissed the third-party complaint. Discovery has been completed and both parties have filed motions for summary judgment in connection with the claims and counterclaims. On December 30, 2021, the Court denied both the Company and North Empire’s motions for summary judgment, arguing there were factual issues to be determined at trial. On January 26, 2022, the Company filed a notice of appeal of the summary judgment decision. On February 3, 2022, the Company filed a motion to reargue the Court’s decision denying the Company’s motion for summary judgment. North Empire will file its opposition papers on or before March 31, 2022, and the Company will file reply papers on April 29, 2022. On or about September 12, 2022, the Court issued its Decision and Order denying the Company’s motion to reargue. North Empire filed its opposing brief on December 7, 2022. Both sides were given an opportunity to file a reply brief. The Company filed a reply brief on January 4, 2023 and North Empire filed its reply brief on January 13, 2023. The Appellate Court has scheduled oral argument for the appeal for February 7, 2023. Oral argument was held before the Appellate Court on February 7, 2023. On or about February 28, 2023, the Appellate Court filed its Decision and Order, which affirmed the lower court’s decisions regarding both the Company and North Empire’s motions for summary judgment and sent the case back to the Supreme Court. On March 13, 2023, the Supreme Court referred the case to its Alternative Dispute Program and ordered the cases to mediate. The mediation was held on July 26, 2023 and various settlement options were explored but the mediation did not lead to settlement. On December 21, 2023, a conference with the Court was held and the parties were given dates for various pre-trial filings. The parties are exploring a resolution and the Court has adjourned the pre-trial deadlines. On July 30, 2024, the parties provided the Court with a status update regarding a possible resolution of the action. As such, the Court has instructed the parties to provide a further update on August 13, 2024. The Company intends to vigorously defend any claims made by North Empire. The Company believes it is more likely than not that the counterclaims will be denied.
	b.	In July 2024, the Company was served with a legal complaint filed by Shimon Shukron in the Magistrate’s Court in Herzliya for a monetary award in an amount of NIS 1,895,345 (approximately $510). The plaintiff alleges that due to the fire that broke out at Orgad’s warehouse in January 2023, the fire spread to the plaintiff’s business and caused heavy damage to the structure and contents, inventory of the business and loss of profits. The Company plans to file its statement of defense in September 2024. At this preliminary stage, before any fact finding and pre-trial procedures (including disclosure of documents) have been conducted and before the statement of defense has been prepared and filed, the Company cannot evaluate the chances of the claim to succeed.

 

Note 6 - Goodwill

 

During the third quarter of 2023, the Company merged its two software-as-a-service (“SaaS”) segments into one segment (see Note 7), which also resulted in a change in the Company’s composition of reporting units. In the Company’s financial reporting for June 30, 2024, comparative information for 2023 was restated to reflect the changes in reportable segments.

 

After the restructuring, the aggregate carrying amounts of goodwill allocated to each reporting unit are as follows:

 

		June 30
		2024				2023
SaaS Solutions			603				1,271
Fashion and equipment e-commerce platform			130				132
			733				1,403

 

12

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 7 – Operating Segments

 

Effective July 1, 2023 the Company merged its two SaaS segments into one segment, reducing its reportable segments from three to the following two segments: (i) fashion and equipment e-commerce platform, and (ii) SaaS based innovative artificial intelligence driven measurement solutions. This realignment reflects the way resources are allocated and performance is assessed by the Chief Operating Decision Maker. The fashion and equipment e-commerce platform which represents Orgad’s activity that was acquired by the Company in 2022, mainly operates on Amazon. The SaaS based innovative artificial intelligence driven measurement solutions, or SaaS Solutions operating segment consists of My Size Inc., My Size Israel, My Size LLC and Naiz Fit.

 

In the Company’s financial reporting for six and three-month periods ended June 30, 2024, comparative information for 2023 was restated to reflect the changes in reportable segments.

 

Information related to the operations of the Company’s reportable operating segments is set forth below:

 

		Fashion and equipment e-commerce platform				SaaS Solutions				Total
As of the six months ended June 30, 2024
Revenues from external customers			4,623				340				4,963
Operating loss			(1,042	)			(906	)			(1,948	)

 

		Fashion and equipment e-commerce platform					Saas Solution
As of June 30, 2024:			5,672				2,340
Assets

 

		Fashion and equipment e-commerce platform				SaaS Solutions				Total
As of the six months ended June 30, 2023
Revenues from external customers			1,738				272				2,010
Operating loss			(2,495	)			(1,551	)			(4,046	)

 

13

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 7 – Operating Segments (Cont.)

 

		Fashion and equipment e-commerce platform				SaaS Solutions				Total
As of the three months ended June 30, 2024
Revenues from external customers			1,816				163				1,979
Operating loss			(460	)			(417	)			(877	)

 

		Fashion and equipment e-commerce platform				SaaS Solutions				Total
As of the three months ended June 30, 2023
Revenues from external customers			1,160				130				1,290
Operating loss			(818	)			(736	)			(1,554	)

 

		Fashion and equipment e-commerce platform				SaaS Solutions				Total
As of the year ended December 31, 2023
Revenues from external customers			6,367				629				6,996
Operating loss			(3,356	)			(3,385	)			(6,741	)

 

		Fashion and equipment e-commerce platform					SaaS Solutions
As of December 31, 2023:
Assets			6,352				2,639

 

14

 

MY SIZE, INC. AND ITS SUBSIDIARIES

 

Notes to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S. dollars in thousands (except share data and per share data)

 

Note 8 – Significant events during the reporting period

 

a.

Further to note 16 to the Company’s 10-K for the year ended December 31, 2023, which was filed with the SEC on April 1, 2024, the Company agreed to pay to the former owners of Orgad on the two-year and the three-year anniversary anniversaries of the closing of the transaction pursuant to which the Company acquired 100% of the shares and voting interests in Orgad, $350 in each of these years, provided that in the case of the second and third instalments certain revenue targets are met and subject further to certain downward post-closing adjustment. In February 2024, the amount of $700 was fully paid to the former owners of Orgad net of a settlement amount of $275.

 

	b.	On January 8, 2024, the Company provided a notice of six month termination to the lessor that the office lease agreement will end on July 8, 2024 instead of August 20, 2025.
		As a result the Company reduced its “Right of use asset” against current liabilities as “Operating lease liability” and in the non-current liabilities as “Operating lease liability – long term” on the Company’s June 30, 2024 consolidated balance sheets in an amount of $181.
	c.	During February 2024, the Company received a loan from a commercial lender in an amount of $500. The loan bears interest at a fix rate of 6% of the principal and payable in installments during six month term.

 

	d.	On April 19, 2024, the Company effected a one-for-eight reverse stock split of its common stock (the “Reverse Stock Split”) with the Company’s shares beginning trading on a post-split basis on the Nasdaq Capital Market on April 23, 2024. Upon the Reverse Stock Split, every eight shares of the Company’s issued and outstanding common stock was automatically converted into one share of common stock, without any change in the par value per share. In addition, a proportionate adjustment was made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding options and warrants entitling the holders to purchase common stock. Any fraction of a share of common stock that would otherwise have resulted from the Reverse Stock Split was rounded up to the next whole number.
	e.	On November 3, 2023, the Company was notified, by the Nasdaq Listing Qualifications that the Company is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on the Nasdaq. The Notification Letter provided that the Company had 180 calendar days, or until May 1, 2024, to regain compliance with the Rule. To regain compliance, the bid price of the Company’s common stock must have had a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. On May 7, 2024, the Company received a letter from Nasdaq that, for the 10 consecutive business days from April 23, 2024 to May 6, 2024, the closing bid price of the Company’s common stock had been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the prior bid price deficiency matter now closed.
	f.	On May 16, 2024, the Company entered into an inducement offer letter agreement (the “Inducement Letter”) with a certain holder (the “Holder”) of certain of the Company’s existing warrants to purchase up to (i) 326,514 shares of the Company’s common stock issued on August 28, 2023 with a twenty-eight month term at an exercise price of $16.72 per share and (ii) 344,475 shares of the Company’s common stock issued on August 28, 2023 with a five and one-half year term at an exercise price of $16.72 per share, ((i) and (ii) collectively, the “Existing Warrants).   Pursuant to the Inducement Letter, the Holder agreed to exercise for cash its Existing Warrants to purchase an aggregate of 670,989 shares of the Company’s common stock at a reduced exercise price of $4.86 per share in consideration of the Company’s agreement to issue new common stock purchase warrants (the “New Warrants”) to purchase up to an aggregate of 1,341,978 shares of the Company’s common stock, at an exercise price of $4.61 per share. The Company received aggregate gross proceeds of approximately $3.26 million from the exercise of the Existing Warrants by the Holder, before deducting placement agent fees and other offering expenses payable by the Company. As of June 30, 2024, the Company issued to the Holder 166,989 of the shares exercised with the remaining  504,000 share held  in abeyance.   The Company engaged H.C. Wainwright & Co., LLC (the “Placement Agent”) to act as its exclusive placement agent in connection with the transactions contemplated by the Inducement Letter and paid the Placement Agent a cash fee equal to 7.0% of the aggregate gross proceeds received from the Holder’s exercise of the Existing Warrants, as well as a management fee equal to 1.0% of the gross proceeds from the exercise of the Existing Warrants. Upon exercise for cash of any New Warrants, the Company has agreed in certain circumstances to pay the Placement Agent a cash fee of 7.0% of the aggregate gross exercise price paid in cash with respect the exercise of the New Warrants, and a management fee of 1.0 % of the aggregate gross exercise price paid in cash with respect to the New Warrants. The Company also issued to the Placement Agent or its designees warrants (the “Placement Agent Warrants”) to purchase up to 46,969 shares of common stock (representing 7.0% of the Existing Warrants being exercised), which have the same terms as the New Warrants except the Placement Agent Warrants have an exercise price equal to $6.075 per share (125% of the reduced exercise price of the Existing Warrants). Similar to the New Warrants, the Placement Agent Warrants were immediately exercisable from the date of issuance until the five and one-half year anniversary of such date. In addition, the Company paid the Placement Agent up to $85 for non-accountable expenses and other out-of-pocket expenses and $16 for clearing fees.

 

15

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis provides information that we believe to be relevant to an assessment and understanding of our results of operations and financial condition for the periods described. This discussion should be read together with our condensed consolidated interim financial statements and the notes to the financial statements, which are included in this Quarterly Report on Form 10-Q. This information should also be read in conjunction with the information contained in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission, or the SEC on April 1, 2024, or the Annual Report, including the consolidated annual financial statements as of December 31, 2023 and their accompanying notes included therein.

 

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended or the Exchange Act. Any statements in this Quarterly Report on Form 10-Q about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as “believe,” “will,” “expect,” “anticipate,” “estimate,” “intend,” “plan” and “would.” For example, statements concerning financial condition, possible or assumed future results of operations, growth opportunities, industry ranking, plans and objectives of management, markets for our common stock and future management and organizational structure are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement.

 

Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed throughout this Quarterly Report on Form 10-Q. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to:

 

	●	our history of losses and needs for additional capital to fund our operations and our inability to obtain additional capital on acceptable terms, or at all;
	●	risks related to our ability to continue as a going concern;
	●	the new and unproven nature of the measurement technology markets;
	●	our ability to achieve customer adoption of our products;
	●	our ability to realize the benefits of our acquisitions of Orgad and Naiz;
	●	our dependence on assets we purchased from a related party;
	●	our ability to enhance our brand and increase market awareness;
	●	our ability to introduce new products and continually enhance our product offerings;
	●	the success of our strategic relationships with third parties;
	●	information technology system failures or breaches of our network security;
	●	competition from competitors;
	●	our reliance on key members of our management team;
	●	current or future litigation;
	●	current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk; and
	●	the impact of the political and security situation in Israel on our business.

 

16

 

The foregoing list sets forth some, but not all, of the factors that could affect our ability to achieve results described in any forward-looking statements. You should read this Quarterly Report on Form 10-Q and the documents that we reference herein and have filed as exhibits to the Quarterly Report on Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect. You should assume that the information appearing in this Quarterly Report on Form 10-Q is accurate as of the date hereof. Because the risk factors referred to on page 18 of our Annual Report, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of the information presented in this Quarterly Report on Form 10-Q, and particularly our forward-looking statements, by these cautionary statements.

 

Unless the context otherwise requires, all references to “we,” “us,” “our” or “the Company” in this Quarterly Report on Form 10-Q are to MySize, Inc., a Delaware corporation, and its subsidiaries, including MySize Israel 2014 Ltd. My Size LLC, Orgad International Marketing Ltd., or Orgad, and Naiz Bespoke Technologies, S.L, or Naiz Fit, taken as a whole.

 

References to “U.S. dollars” and “$” are to currency of the United States of America, and references to “NIS” are to New Israeli Shekels. Unless otherwise indicated, U.S. dollar translations of NIS amounts presented in this Quarterly Report on Form 10-Q for three months ended on June 30, 2024 are translated using the rate of NIS 3.759 to $1.00.

 

All information in this Quarterly Report on Form 10-Q relating to shares or price per share reflects the 1-for-8 reverse stock split effected by us on April 19, 2024 with the shares beginning trading on a post-split basis on the Nasdaq Capital Market on April 23, 2024.

 

Overview

 

We are an omnichannel e-commerce platform and provider of AI-driven software-as-a-service (“SaaS”) measurement solutions, including MySizeID and our subsidiaries, Naiz Fit, which provides SaaS technology solutions that solve size and fit issues and AI solutions for smarter design through data driven decisions for fashion ecommerce companies, and Orgad, an online retailer operating in the global markets. To date, we have generated almost all our revenue as a third-party seller on Amazon. Our advanced software and solutions assists us in the supply chain, identifying products that can drive growth and provides a user-friendly experience and best customer service.

 

Our flagship innovative tech product, MySizeID, enables shoppers to generate highly accurate measurements of their body to find the accurate fitting apparel by using our application on their mobile phone or through the MySizeID Widget: a simple questionnaire which uses a database collected over the years.

 

MySizeID syncs the user’s measurement data to a sizing chart integrated through a retailer’s (or a white labeled) mobile application, and only presents items for purchase that match their measurements to ensure a correct fit.

 

We are positioning ourselves as a consolidator of sizing solutions and a provider of a new digital experience due to recent technological developments for the fashion industry needs. Our other product offerings include First Look Smart Mirror for physical stores and Smart Catalog to empower brand design teams, which are designed to increase end consumer satisfaction, contributing to a sustainable world and reducing operation costs.

 

Recent Developments

 

Hamas-Israel War

 

In October 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel’s border with the Gaza Strip and in other areas within the State of Israel. These attacks resulted in thousands of deaths and injuries, and Hamas additionally kidnapped many Israeli civilians and soldiers. Following the attack, Israel’s security cabinet declared war against Hamas and commenced a military campaign against Hamas and other terrorist organizations in parallel to their continued rocket and terror attacks. In addition, since the commencement of these events, there have been continued hostilities along Israel’s northern border with Lebanon (with the Hezbollah terror organization) and southern border (with the Houthi movement in Yemen). It is possible that hostilities with Hezbollah in Lebanon will escalate, and that other terrorist organizations, including Palestinian military organizations in the West Bank as well as other hostile countries will join the hostilities. In addition, Iran recently launched a direct attack on Israel involving hundreds of drones and missiles and has threatened to continue to attack Israel and is widely believed to be developing nuclear weapons. Iran is also believed to have a strong influence among extremist groups in the region, such as Hamas in Gaza, Hezbollah in Lebanon, the Houthi movement in Yemen and various rebel militia groups in Syria and Iraq. Such clashes may escalate in the future into a greater regional conflict. To date, the war with Hamas has had an immaterial effect on our operations and financial results. This is attributable to our global footprint and the offices in Spain, which has become a hub for our sizing solutions business and the majority of Orgad’s inventory utilizes fulfillment by Amazon rather than fulfilling directly.

 

17

 

Results of Operations

 

The table below provides our results of operations for the periods indicated.

 

		Three months ended June 30								Six months ended June 30
		2024				2023				2024				2023
		(dollars in thousands)								(dollars in thousands)
Revenues		$	1,979			$	1,290			$	4,963			$	2,010
Cost of revenues			(995	)			(771	)			(2,783	)			(1,918	)
Gross profit			984				519				2,180				92
Research and development expenses			(131	)			(227	)			(263	)			(569	)
Sales and marketing			(831	)			(967	)			(1,933	)			(1,646	)
General and administrative			(899	)			(879	)			(1,932	)			(1,923	)
Operating loss			(877	)			(1,554	)			(1,948	)			(4,046	)
Financial income (expenses), net			(87	)			46				(32	)			(100	)
Equity accounted losses			-				(5	)			-				(39	)
Tax income			-				222				-				240
Net loss		$	(964	)		$	(1,291	)		$	(1,980	)		$	(3,945	)

 

Six and Three Months Ended June 30, 2024 Compared to Six and Three Months Ended June 30, 2023

 

Revenues

 

Our revenues for the six months ended June 30, 2024 amounted to $4,963,000 compared to $2,010,000 for the six months ended June 30, 2023. The increase in the six months ended June 30, 2024 from the corresponding period is primarily attributable to an increase in Orgad sales.

 

Our revenues for the three months ended June 30, 2024 amounted to $1,979,000 compared to $1,290,000 for the three months ended June 30, 2023. The increase in the three months ended June 30, 2024 from the corresponding period is primarily attributable to an increase in Orgad sales.

 

Cost Of Revenues

 

Our cost of revenues expenses for the six months ended June 30, 2024 amounted to $2,783,000 compared to $1,918,000 for the six months ended June 30, 2023. The increase in comparison with the corresponding period was mainly due to an increase in revenues described above offset by an inventory mark-down of $643,000 due to the fire that occurred in Orgad’s warehouse during January 2023.

 

Our cost of revenues expenses for the three months ended June 30, 2024 amounted to $995,000 compared to $771,000 for the three months ended June 30, 2023. The increase in comparison with the corresponding period was mainly due to an increase in revenues described above.

 

Research and Development Expenses

 

Our research and development expenses for the six months ended June 30, 2024 amounted to $263,000 compared to $569,000 for the six months ended June 30, 2023. The decrease from the corresponding period was mainly due to a decrease in salaries expenses due to reduced headcount and a decrease in subcontractor expenses.

 

Our research and development expenses for the three months ended June 30, 2024 amounted to $131,000 compared to $227,000 for the three months ended June 30, 2023. The decrease from the corresponding period was mainly due to a decrease in salaries expenses due to reduced headcount and a decrease in subcontractor expenses.

 

18

 

Sales and Marketing Expenses

 

Our sales and marketing expenses for the six months ended June 30, 2024 amounted to $1,933,000 compared to $1,646,000 for the six months ended June 30, 2023. The increase primarily resulted from an increase in Amazon fees due to the increase in sales offset by a decrease in salary expenses due to reduced headcount, consultant expenses, travel and marketing expenses.

 

Our sales and marketing expenses for the three months ended June 30, 2024 amounted to $831,000 compared to $967,000 for the three months ended June 30, 2023. The decrease primarily resulted from a decrease in salary expenses due to reduced headcount, consultant expenses, travel and marketing expenses offset by an increase in Amazon fees due to the increase in sales.

 

General and Administrative Expenses

 

Our general and administrative expenses for the six months ended June 30, 2024 amounted to $1,932,000 compared to $1,923,000 for the six months ended June 30, 2023.

 

Our general and administrative expenses for the three months ended June 30, 2024 amounted to $899,000 compared to $879,000 for the three months ended June 30, 2023.

 

Operating Loss

 

As a result of the foregoing, for the six months ended June 30, 2024, our operating loss was $1,948,000 a decrease of $2,098,000 or 51.9%, compared to our operating loss for the six months ended June 30, 2023 of $4,046,000.

 

As a result of the foregoing, for the three months ended June 30, 2024, our operating loss was $877,000 a decrease of $677,000 or 43.6%, compared to our operating loss for the three months ended June 30, 2023 of $1,554,000.

 

Financial Income (Expenses), Net

 

Our financial expenses, net for the six months ended June 30, 2024 amounted to $32,000 compared to financial expenses of $100,000 for the six months ended June 30, 2023 The decrease compared to the corresponding period was mainly due to a decrease in financial expenses exchange rate differences.

 

Our financial expenses, net for the three months ended June 30, 2024 amounted to $87,000 as opposed to financial income of $46,000 for the three months ended June 30, 2023. During the three months ended June 30, 2024, we had financial expenses mainly from exchange rate differences whereas in the three months ended June 30, 2023 we had financial income from exchange rate differences.

 

Net Loss

 

As a result of the foregoing, our net loss for the six months ended June 30, 2024 was $1,980,000, compared to net loss of $3,945,000 for the six months ended June 30, 2023. The decrease in net loss was mainly due to the reasons mentioned above.

 

As a result of the foregoing, our net loss for the three months ended June 30, 2024 was $964,000, compared to net loss of $1,291,000 for the three months ended June 30, 2023. The decrease in net loss was mainly due to the reasons mentioned above.

 

19

 

Liquidity and Capital Resources

 

Since our inception, we have funded our operations primarily through public and private offerings of debt and equity securities in the State of Israel and in the United States

 

As of June 30, 2024, we had cash, cash equivalents, and restricted cash of $3,275,000 compared to $2,264,000 of cash, cash equivalents and restricted cash as of December 31, 2023. This increase primarily resulted from the warrant repricing transaction that was completed in May 2024, offset by payments that were made to suppliers, resources that were deployed to grow our businesses and payments related to the Orgad acquisition.

 

Cash used in operating activities amounted to $2,076,000 for the six months ended June 30, 2024, compared to $3,640,000 for the six months ended June 30, 2023. The decrease in cash used in operating activity is derived mainly from a change in inventory and a decrease in the net loss offset by a change in account receivables and trade payables.

 

Net cash provided by investing activities was $60,000 or the six months ended June 30, 2024, compared to none for the six months ended June 30, 2023.

 

Net cash provided by financing activities was $2,961,000 for the six months ended June 30, 2024, compared to $2,596,000 for the six months ended June 30, 2023. The cash flow from financing activities for the six months ended June 30, 2024 resulted from the May 2024 warrant repricing transaction and a loan that was received compared to the public and private offering that occurred in January 2023.

 

We expect that we will continue to generate losses and negative cash flows from operations for the foreseeable future. Based on the projected cash flows and cash balances as of June 30, 2024, we believe our existing cash will not be sufficient to fund operations for a period of more than 12 months. As a result, there is substantial doubt about our ability to continue as a going concern. We will need to raise additional capital, which may not be available on reasonable terms or at all. Additional capital would be used to accomplish the following:

 

	●	finance our current operating expenses;
	●	pursue growth opportunities;
	●	hire and retain qualified management and key employees;
	●	respond to competitive pressures;
	●	comply with regulatory requirements; and
	●	maintain compliance with applicable laws.

 

Current conditions in the capital markets are such that traditional sources of capital may not be available to us when needed or may be available only on unfavorable terms. Our ability to raise additional capital, if needed, will depend on conditions in the capital markets, economic conditions the current war between Israel and Hamas, and a number of other factors, many of which are outside our control, and on our financial performance. Accordingly, we cannot assure you that we will be able to successfully raise additional capital at all or on terms that are acceptable to us. If we cannot raise additional capital when needed, it may have a material adverse effect on our business, results of operations and financial condition.

 

To the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of such securities could result in substantial dilution for our current stockholders. The terms of any securities issued by us in future capital-raising transactions may be more favorable to new investors, and may include preferences, superior voting rights and the issuance of warrants or other derivative securities, which may have a further dilutive effect on the holders of any of our securities then-outstanding. We may issue additional shares of our common stock or securities convertible into or exchangeable or exercisable for our common stock in connection with hiring or retaining personnel, option or warrant exercises, future acquisitions or future placements of our securities for capital-raising or other business purposes. The issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our common stock to decline and existing stockholders may not agree with our financing plans or the terms of such financings. In addition, we may incur substantial costs in pursuing future capital financing, including investment banking fees, legal fees, accounting fees, securities law compliance fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash expenses in connection with certain securities we issue, such as convertible notes and warrants, which may adversely impact our financial condition. Furthermore, any additional debt or equity financing that we may need may not be available on terms favorable to us, or at all. If we are unable to obtain such additional financing on a timely basis, we may have to curtail our development activities and growth plans and/or be forced to sell assets, perhaps on unfavorable terms, or we may have to cease our operations, which would have a material adverse effect on our business, results of operations and financial condition.

 

We have not entered into any transactions with unconsolidated entities in which we have financial guarantees, subordinated retained interests, derivative instruments or other contingent arrangements that expose us to material continuing risks, contingent liabilities or any other obligations under a variable interest in an unconsolidated entity that provides us with financing, liquidity, market risk or credit risk support.

 

20

 

Critical Accounting Estimates

 

Our management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which we have prepared in accordance with U.S. generally accepted accounting principles issued by the Financial Accounting Standards Board. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported expenses during the reporting periods. Actual results may differ from these estimates under different assumptions or conditions.

 

Our significant accounting policies were revenue from contracts with customers which are more fully described in the notes to our financial statements included herein. We believe these accounting policies discussed below are critical to our financial results and to the understanding of our past and future performance, as these policies relate to the more significant areas involving management’s estimates and assumptions. We consider an accounting estimate to be critical if: (1) it requires us to make assumptions because information was not available at the time or it included matters that were highly uncertain at the time we were making our estimate; and (2) changes in the estimate could have a material impact on our financial condition or results of operations.

 

Item 3. Quantitative and Qualitative Disclosure About Market Risk.

 

Not required for a smaller reporting company.

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Exchange Act, and the rules and regulations thereunder, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

As required by Rule 13a-15(b) under the Exchange Act, our management, under the supervision and with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2024. Based upon such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of June 30, 2024 were effective.

 

Our Chief Executive Officer and Chief Financial Officer do not expect that our disclosure controls and procedures or our internal controls will prevent all error or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

 

Changes in Internal Controls

 

During the most recent fiscal quarter, no change has occurred in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

21

 

Part II – Other Information

 

Item 1. Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

 

North Empire LLC

 

On August 7, 2018, we commenced an action against North Empire LLC, or North Empire, in the Supreme Court of the State of New York, County of New York for breach of a Securities Purchase Agreement or Agreement in which we are seeking damages in an amount to be determined at trial, but in no event less than $616,000. On August 2, 2018, North Empire filed a Summons with Notice against us, also in the same Court, in which they allege damages in an amount of $11.4 million arising from an alleged breach of the Agreement. On September 6, 2018, North Empire filed a Notice of Discontinuance of the action it had filed on August 2, 2018. On September 27, 2018, North Empire filed an answer and asserted counterclaims in the action commenced by us against them, alleging that we failed to deliver stock certificates to North Empire causing damage to North Empire in the amount of $10,958,589. North Empire also filed a third-party complaint against our CEO and now former Chairman of the Board asserting similar claims against them in their individual capacities. On October 17, 2018, we filed a reply to North Empire’s counterclaims. On November 15, 2018, our CEO and now former Chairman of the Board filed a motion to dismiss North Empire’s third-party complaint. On January 6, 2020, the Court granted the motion and dismissed the third-party complaint. Discovery has been completed and both parties have filed motions for summary judgment in connection with the claims and counterclaims. On December 30, 2021, the Court denied both My Size and North Empire’s motions for summary judgment, arguing there were factual issues to be determined at trial. On January 26, 2022, the Company filed a notice of appeal of the summary judgment decision. On February 3, 2022, the Company filed a motion to reargue the Court’s decision denying the Company’s motion for summary judgment. On or about September 12, 2022, the Court issued its Decision and Order denying the Company’s motion to reargue. North Empire filed its opposing brief on December 7, 2022. Both sides were given an opportunity to file a reply brief. We filed our reply brief on January 4, 2023 and North Empire filed its reply brief on January 13, 2023. Oral argument was held before the Appellate Court on February 7, 2023. On or about February 28, 2023, the Appellate Court filed its Decision and Order, which affirmed the lower court’s decisions regarding both My Size and North Empire’s motions for summary judgment and sent the case back to the Supreme Court. On or about March 13, 2023, the Supreme Court referred the case to its Alternative Dispute Program and ordered the cases to mediate. The mediation was held on July 26, 2023 and various settlement options were explored but the mediation did not lead to settlement. On December 21, 2023, a conference with the Court was held and the parties were given dates for various pre-trial filings. The parties are exploring a resolution and the Court has adjourned the pre-trial deadlines. On July 30, 2024, the parties provided the Court with a status update regarding a possible resolution of the action. As such, the Court has instructed the parties to provide a further update on August 13, 2024. We intend to vigorously defend any claims made by North Empire. We believe it is more likely than not that the counterclaims will be denied.

 

Shimon Shukron

 

In July 2024, we were served with a legal complaint filed by Shimon Shukron in the Magistrate’s Court in Herzliya for a monetary award in an amount of NIS 1,895,345 (approximately $510,000). The plaintiff alleges that due to the fire that broke out at Orgad’s warehouse in January 2023, the fire spread to the plaintiff’s business and caused heavy damage to the structure and contents, inventory of the business and loss of profits. We expect to file our statement of defense in September 2024. At this preliminary stage, before any fact finding and pre-trial procedures (including disclosure of documents) have been conducted and before the statement of defense has been prepared and filed, we cannot evaluate the chances of the claim to succeed.

 

Item 1A. Risk Factors.

 

Except as set forth below in this Item 1A and the Risk Factors included in our previous filings made with the SEC, there have been no material changes to our risk factors from those disclosed in “Part I. Item 1A. Risk Factors” in the Form 10-K filed with the SEC on April 1, 2024.

 

22

 

Our headquarters and some of our operations are located in Israel, and therefore, political, economic and military conditions in Israel may affect our operations and results.

 

Our headquarters and some of our operations are located in central Israel and our key employees, officers and directors are residents of Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region may directly affect our business and operations. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its Arab neighbors. Any hostilities involving Israel or the interruption or curtailment of trade within Israel or between Israel and its trading partners could adversely affect our operations and results of operations and could make it more difficult for us to raise capital.

 

In particular, in October 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel’s border with the Gaza Strip and in other areas within the State of Israel. These attacks resulted in thousands of deaths and injuries, and Hamas additionally kidnapped many Israeli civilians and soldiers. Following the attack, Israel’s security cabinet declared war against Hamas and commenced a military campaign against Hamas and these terrorist organizations in parallel continued rocket and terror attacks. As a result of the events of October 7, 2023, the Israeli government declared that the country was at war and the Israeli military began to call-up reservists for active duty. None of our full-time or part-time employees in Israel were called up for reserve service. Military service call ups that result in absences of personnel from us for an extended period of time may materially and adversely affect our business, prospects, financial condition and results of operations.

 

Since the war broke out on October 7, 2023, our operations have not been adversely affected by this situation, and we have not experienced disruptions to our business operations. In particular, most of our operations are in Spain. However, the intensity and duration of Israel’s current war against Hamas is difficult to predict at this stage, as are such war’s economic implications on our business and operations and on Israel’s economy in general. If the war extends for a long period of time or expands to other fronts, such as Lebanon, Syria and the West Bank, our operations may be adversely affected.

 

In addition, since the commencement of these events, there have been continued hostilities along Israel’s northern border with Lebanon (with the Hezbollah terror organization) and southern border (with the Houthi movement in Yemen). It is possible that hostilities with Hezbollah in Lebanon will escalate, and that other terrorist organizations, including Palestinian military organizations in the West Bank as well as other hostile countries will join the hostilities. Such clashes may escalate in the future into a greater regional conflict. In addition, Iran recently launched a direct attack on Israel involving hundreds of drones and missiles and has threatened to continue to attack Israel and is widely believed to be developing nuclear weapons. Iran is also believed to have a strong influence among extremist groups in the region, such as Hamas in Gaza, Hezbollah in Lebanon, the Houthi movement in Yemen and various rebel militia groups in Syria. These situations may potentially escalate in the future to more violent events which may affect Israel and us. Any armed conflicts, terrorist activities or political instability in the region could adversely affect business conditions, could harm our results of operations and could make it more difficult for us to raise capital. Parties with whom we do business may decline to travel to Israel during periods of heightened unrest or tension, forcing us to make alternative arrangements when necessary in order to meet our business partners face to face. In addition, the political and security situation in Israel may result in parties with whom we have agreements involving performance in Israel claiming that they are not obligated to perform their commitments under those agreements pursuant to force majeure provisions in such agreements. Further, in the past, the State of Israel and Israeli companies have been subjected to economic boycotts. Several countries still restrict business with the State of Israel and with Israeli companies. These restrictive laws and policies may have an adverse impact on our operating results, financial condition or the expansion of our business. Any hostilities involving Israel or the interruption or curtailment of trade between Israel and its trading partners could adversely affect our operations and results of operations. In recent years, the hostilities involved missile strikes against civilian targets in various parts of Israel, including areas in which our employees and some of our consultants are located, and negatively affected business conditions in Israel.

 

Our commercial insurance does not cover losses that may occur as a result of events associated with the security situation in the Middle East. Although the Israeli government currently covers the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that this government coverage will be maintained. Any losses or damages incurred by us could have a material adverse effect on our business. Any armed conflicts or political instability in the region would likely negatively affect business conditions and could harm our results of operations.

 

The continued political instability and hostilities between Israel and its neighbors and any future armed conflict, terrorist activity or political instability in the region could adversely affect our operations in Israel and adversely affect the market price of our shares of common stock. In addition, several organizations and countries may restrict doing business with Israel and Israeli companies have been and are today subjected to economic boycotts. The interruption or curtailment of trade between Israel and its present trading partners could adversely affect our business, financial condition and results of operations.

 

Finally, political conditions within Israel may affect our operations. Israel has held five general elections between 2019 and 2022, and prior to October 2023, the Israeli government pursued extensive changes to Israel’s judicial system, which sparked extensive political debate and unrest. To date, these initiatives have been substantially put on hold. Actual or perceived political instability in Israel or any negative changes in the political environment, may individually or in the aggregate adversely affect the Israeli economy and, in turn, our business, financial condition, results of operations and growth prospects.

 

23

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

During the quarter ended June 30, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (in each case, as defined in Item 408 of Regulation S-K).

 

Item 6. Exhibits.

 

Exhibit Number		Description of Exhibits
31.1*		Certification of Principal Executive Officer pursuant to 18 U.S.C Section 1350, as adopted Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*		Certification of Principal Executive Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*		Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Schema
101.CAL*		Inline XBRL Taxonomy Calculation Linkbase
101.DEF*		Inline XBRL Taxonomy Definition Linkbase
101.LAB*		Inline XBRL Taxonomy Label Linkbase
101.PRE*		Inline XBRL Taxonomy Presentation Linkbase
104*		Cover Page Interactive Data File (formatted as Inline XBRL document and contained in Exhibit 101)

 

*	Filed herewith

 

24

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	My Size, Inc.
Date: August 12, 2024	By:	/s/ Ronen Luzon
		Ronen Luzon
		Chief Executive Officer (Principal Executive Officer)
Date: August 12, 2024	By:	/s/ Or Kles
		Or Kles
		Chief Financial Officer (Principal Financial and Accounting Officer)

 

25

 

 

Exhibit 31.1

 

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002 and pursuant to Rule 13a-14(a) and Rule 15d-14 under the

Securities Exchange Act of 1934

 

I, Ronen Luzon certify that:

 

1.	I have reviewed this Quarterly Report on Form 10-Q of My Size, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c.	Evaluated the effectiveness of the registrant’s disclosure and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations: and
	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 12, 2024	By:	/s/ Ronen Luzon
		Ronen Luzon
		Chief Executive Officer (Principal Executive Officer)

 

 

 

Exhibit 31.2

 

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002 and pursuant to Rule 13a-14(a) and Rule 15d-14 under the

Securities Exchange Act of 1934

 

I, Or Kles, certify that:

 

1	I have reviewed this Quarterly Report on Form 10-Q of My Size, Inc.;
2	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c.	Evaluated the effectiveness of the registrant’s disclosure and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations: and
	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 12, 2024	By:	/s/ Or Kles
		Or Kles
		Chief Financial Officer (Principal Financial and Accounting Officer)

 

 

 

 

 

Exhibit 32.1

 

CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

In connection with the Quarterly Report of My Size, Inc. (the “Company”) In connection with the Quarterly Report for the quarter ended June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ronen Luzon, Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Company’s Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: August 12, 2024	By:	/s/ Ronen Luzon
		Ronen Luzon
		Chief Executive Officer (Principal Executive Officer)

 

 

 

Exhibit 32.2

 

CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

In connection with the Quarterly Report of My Size, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Or Kles, Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Company’s Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: August 12, 2024	By:	/s/ Or Kles
		Or Kles
		Chief Financial Officer (Principal Financial and Accounting Officer)

 

 

 

 

Cover - $ / shares	6 Months Ended
	Jun. 30, 2024	Aug. 01, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	001-37370
Entity Registrant Name	MY SIZE, INC.
Entity Central Index Key	0001211805
Entity Tax Identification Number	51-0394637
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	HaNegev 4
Entity Address, Address Line Two	POB 1026
Entity Address, City or Town	Airport City
Entity Address, Country	IL
Entity Address, Postal Zip Code	7010000
City Area Code	972
Local Phone Number	3-600-9030
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	MYSZ
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		1,067,131
Entity Listing, Par Value Per Share	$ 0.001

Condensed Consolidated Interim Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 3,201	$ 2,187
Restricted cash	74	77
Short term deposit		22
Inventory	1,793	2,879
Account receivables	329	615
Other receivables and prepaid expenses	807	847
Total current assets	6,204	6,627
Long term deposits	7	7
Property and equipment, net	107	121
Operating right-of-use asset	32	351
Intangible assets	919	1,097
Goodwill	733	758
Investment in JV		24
Investment in marketable securities	10	6
Total non-current assets	1,808	2,364
Total assets	8,012	8,991
Current liabilities:
Operating lease liability	17	158
Bank overdraft and short-term loans	423	158
Trade payables	896	2,154
Liabilities to Related parties	70	605
Other payables	703	803
Total current liabilities	2,109	3,878
Long-term loans	193	249
Operating lease liability	15	129
Total non-current liabilities	208	378
Total liabilities	2,317	4,256
COMMITMENTS AND CONTINGENCIES
Stockholders’ equity:
Common stock of $0.001 par value - Authorized: 250,000,000 shares; Issued and outstanding: 883,131(*) and 452,724(*) as of June 30, 2024 and December 31, 2023, respectively	1	1
Additional paid-in capital	68,425	65,386
Accumulated other comprehensive loss	(870)	(771)
Accumulated deficit	(61,861)	(59,881)
Total stockholders’ equity	5,695	4,735
Total liabilities and stockholders’ equity	$ 8,012	$ 8,991

Condensed Consolidated Interim Balance Sheets (Unaudited) (Parenthetical) - $ / shares		Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Common stock, par value		$ 0.001	$ 0.001
Common stock, shares authorized		250,000,000	250,000,000
Common stock, shares issued	[1]	883,131	452,724
Common stock, shares outstanding	[1]	883,131	452,724
[1] Adjusted to give retroactive effect of 1:8 Reverse stock split, see note 8 (d)

Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenues		$ 1,979	$ 1,290	$ 4,963	$ 2,010
Cost of revenues	[1]	(995)	(771)	(2,783)	(1,918)
Gross profit		984	519	2,180	92
Operating expenses
Research and development		(131)	(227)	(263)	(569)
Sales and marketing		(831)	(967)	(1,933)	(1,646)
General and administrative		(899)	(879)	(1,932)	(1,923)
Total operating expenses		(1,861)	(2,073)	(4,128)	(4,138)
Operating loss		(877)	(1,554)	(1,948)	(4,046)
Financial income (expenses), net		(87)	46	(32)	(100)
Equity loss of equity method investees	[2]		(5)		(39)
Loss before taxes		(964)	(1,513)	(1,980)	(4,185)
Taxes on income			222		240
Net loss		(964)	(1,291)	(1,980)	(3,945)
Other comprehensive income (loss):
Foreign currency translation differences		8	(24)	(99)	(39)
Total comprehensive loss		$ (956)	$ (1,315)	$ (2,079)	$ (3,984)
Basic loss per share	[3]	$ (1.28)	$ (4.24)	$ (3.06)	$ (14.40)
Diluted loss per share	[3]	$ (1.28)	$ (4.24)	$ (3.06)	$ (14.40)
Basic weighted average number of shares outstanding	[3]	755,600	305,519	647,321	273,845
Diluted weighted average number of shares outstanding	[3]	755,600	305,519	647,321	273,845
[1] During the six months ended June 30, 2023, the Company recorded an inventory write-down of $643 due to the fire that occurred in its warehouse). [2] In March 2024, the Company closed a joint venture (the “JV”) in Brazil with Santista Têxtil. [3] Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d).

Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited) (Parenthetical) $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($)
Income Statement [Abstract]
Inventory mark-down	$ 643

Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands		Common Stock [Member]		Additional Paid-in Capital [Member]		AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022		$ 1	[1],[2]	$ 58,673	[1],[2]	$ (637)	$ (53,501)	$ 4,536
Balance, shares at Dec. 31, 2022	[1],[2]	183,015
Stock-based compensation related to options and restricted shares granted to employees and consultants			[2],[3]	222	[2]			222
Stock-based compensation related to options and restricted shares granted to employees and consultants, shares	[2]	(1,000)
Issuance of shares, net of issuance cost	[2]		[3]	2,658				2,658
Issuance of shares, net of issuance cost, shares	[2]	20,250
Total comprehensive loss			[2]		[2]	(39)	(3,945)	(3,984)
Exercise of warrants and prefunded warrants			[2],[3]	1	[2]			1
Exercise of warrants and prefunded warrants, shares	[2]	102,583
Balance at Jun. 30, 2023		$ 1	[2],[4]	61,554	[2],[4]	(676)	(57,446)	3,433
Balance, shares at Jun. 30, 2023	[2],[4]	304,848
Balance at Dec. 31, 2022		$ 1	[1],[2]	58,673	[1],[2]	(637)	(53,501)	4,536
Balance, shares at Dec. 31, 2022	[1],[2]	183,015
Stock-based compensation related to options and restricted shares granted to employees and consultants			[1],[5]	453	[1]			453
Stock-based compensation related to options and restricted shares granted to employees and consultants, shares	[1]	(1,000)
Issuance of shares, net of issuance cost			[1],[5]	6,258	[1]			6,258
Issuance of shares, net of issuance cost, shares	[1]	54,000
Exercise of shares in abeyance			[1],[5]	2	[1]			2
Exercise of shares in abeyance, shares	[1]	216,709
Total comprehensive loss			[1]		[1]	(134)	(6,380)	(6,514)
Balance at Dec. 31, 2023		$ 1	[1],[6]	65,386	[1],[6]	(771)	(59,881)	4,735
Balance, shares at Dec. 31, 2023	[1],[6]	452,724
Balance at Mar. 31, 2023		$ 1	[4]	61,468	[4]	(652)	(56,155)	4,662
Balance, shares at Mar. 31, 2023	[4]	305,848
Stock-based compensation related to options and restricted shares granted to employees and consultants			[4],[7]	86	[4]			86
Stock-based compensation related to options and restricted shares granted to employees and consultants, shares	[4]	(1,000)
Total comprehensive loss			[4]		[4]	(24)	(1,291)	(1,315)
Balance at Jun. 30, 2023		$ 1	[2],[4]	61,554	[2],[4]	(676)	(57,446)	3,433
Balance, shares at Jun. 30, 2023	[2],[4]	304,848
Balance at Dec. 31, 2023		$ 1	[1],[6]	65,386	[1],[6]	(771)	(59,881)	4,735
Balance, shares at Dec. 31, 2023	[1],[6]	452,724
Stock-based compensation related to options and restricted shares granted to employees and consultants			[6],[8]	217	[6]			217
Stock-based compensation related to options and restricted shares granted to employees and consultants, shares	[6]	80,000
Issuance of shares post Business Combination			[6],[8]	3	[6]			3
Issuance of shares post Business Combination, shares	[6]	4,360
Effect of reverse stock split			[6],[8]		[6]
Effect of reverse stock split, shares	[6]	74,683
Issuance of shares, net of issuance cost			[6]	2,819	[6]			2,819
Issuance of shares, net of issuance cost, shares	[9]	79,000
Exercise of shares in abeyance			[6],[8]		[6]
Exercise of shares in abeyance, shares	[6]	192,364
Total comprehensive loss			[6]		[6]	(99)	(1,980)	(2,079)
Balance at Jun. 30, 2024		$ 1	[6],[10]	68,425	[6],[10]	(870)	(61,861)	5,695
Balance, shares at Jun. 30, 2024	[6],[10]	883,131
Balance at Mar. 31, 2024		$ 1	[10]	65,527	[10]	(878)	(60,897)	3,753
Balance, shares at Mar. 31, 2024	[10]	641,459
Stock-based compensation related to options and restricted shares granted to employees and consultants				79	[10]			79
Effect of reverse stock split			[10],[11]		[10]
Effect of reverse stock split, shares	[10]	74,683
Issuance of shares, net of issuance cost	[12]		[10],[11]	2,819	[10]			2,819
Issuance of shares, net of issuance cost, shares	[10]	79,000
Total comprehensive loss			[10]		[10]	8	(964)	(956)
Exercise of warrants and prefunded warrants			[10],[11]		[10]
Exercise of warrants and prefunded warrants, shares	[10]	87,989
Balance at Jun. 30, 2024		$ 1	[6],[10]	$ 68,425	[6],[10]	$ (870)	$ (61,861)	$ 5,695
Balance, shares at Jun. 30, 2024	[6],[10]	883,131
[1] Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d). [2] Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d). [3] Represents an amount less than $1 [4] Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d). [5] Represents an amount less than $1. [6] Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d). [7] Represents an amount less than $1 [8] Represents an amount less than $1. [9] See note 8 (f). [10] Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d). [11] Represents an amount less than $1 [12] See note 8 (f).

Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Unaudited) (Parenthetical) - USD ($) $ in Thousands		3 Months Ended	6 Months Ended		12 Months Ended
	Apr. 19, 2024	Jun. 30, 2024	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]
Net issuance cost		$ 442	$ 442	$ 341	$ 959
Reverse stock split	1:8 reverse stock split

Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net loss		$ (1,980)	$ (3,945)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		16	16
Change in operating lease right-of-use asset		138	88
Amortization of intangible assets		76	151
Change in liabilities to related parties		(525)	(76)
Interest of long-term liabilities		41	11
Interest paid		(37)	(11)
Revaluation of investment in marketable securities		(4)	23
Change in Investment in JV			39
Stock based compensation		217	222
Change in inventory		1,080	(95)
Change in deferred tax liabilities			(36)
Change in account receivable		282	1,119
Changes in operating lease liabilities		(97)	(68)
Change in other receivables and prepaid expenses		38	(205)
Change in trade payables		(1,212)	(888)
Change in other payables		(109)	15
Net cash used in operating activities		(2,076)	(3,640)
Cash flows from investing activities:
Proceeds from investment in JV		38
Proceeds from short-term deposits		22
Net cash used in investing activities		60
Cash flows from financing activities:
Proceeds from issuance of shares, net of issuance costs		2,819	2,658
Loans received		500
Repayment of loans		(358)	(62)
Net cash provided by financing activities		2,961	2,596
Effect of exchange rate fluctuations on cash and cash equivalents		66	(69)
Increase (decrease) in cash, cash equivalents and restricted cash	[1]	1,011	(1,113)
Cash, cash equivalents and restricted cash at the beginning of the period		2,264	2,363
Cash, cash equivalents and restricted cash at the end of the period		3,275	1,250
Non cash activities:
Change in operating lease right-of-use asset and liability		$ 181
[1] $1,014 relates to change in cash and cash equivalents and, $(3) to change in restricted cash for the six months ended June 30, 2024.

Condensed Consolidated Interim Statements of Cash Flows (Unaudited) (Parenthetical) $ in Thousands	Jun. 30, 2024 USD ($)
Statement of Cash Flows [Abstract]
Cash and cash equivalents	$ 1,014
Restricted cash	$ 3

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ (964)	$ (1,291)	$ (1,980)	$ (3,945)

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

General	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General	Note 1 - General     a. My Size, Inc. (the “Company”) is developing unique measurement technologies based on algorithms with applications in a variety of areas, including the apparel e-commerce market, the courier services market and the Do It Yourself (“DIY”) smartphone and tablet apps market. The technology is driven by proprietary algorithms, which are able to calculate and record measurements in a variety of novel ways.   Following the acquisition of Naiz Fit Bespoke Technologies, S.L (“Naiz”) in October 2022, the Company expanded its offering outreach and customer base.   Following the acquisition of Orgad International Marketing Ltd. (“Orgad”) in February 2022, the Company also operates an omnichannel e-commerce platform.   The Company has six subsidiaries, My Size Israel 2014 Ltd. (“My Size Israel”), Topspin Medical (Israel) Ltd., Orgad and Rotrade Ltd., all of which are incorporated in Israel, My Size LLC, which is incorporated in the Russian Federation and Naiz, a limited liability company incorporated under the laws of Spain. References to the Company include the subsidiaries unless the context indicates otherwise.   My Size, Inc., was incorporated and commenced operations in September 1999, as Topspin Medical Inc. (“Topspin”), a private company registered in the State of Delaware. In December 2013, the Company changed its name to Knowledgetree Ventures Inc. Subsequently, in February 2014, the Company changed its name to My Size, Inc. Topspin was engaged, through its Israeli subsidiary, in research and development in the field of cardiology and urology.   On July 25, 2016, the Company’s common stock began publicly trading on the Nasdaq Capital Market under the symbol “MYSZ”.   From September 1, 2005 to March 27, 2024, the Company’s common stock was traded on the Tel Aviv Stock Exchange.         b. Since inception, the Company has incurred significant losses and negative cash flows from operations and had an accumulated deficit of $61,861. The Company has financed its operations mainly through fundraising from various investors.   The Company’s management expects that the Company will continue to generate losses and negative cash flows from operations for the foreseeable future. Based on the projected cash flows and cash balances as of June 30, 2024, management is of the opinion that its existing cash will not be sufficient to fund operations for a period of more than 12 months. As a result, there is substantial doubt about the Company’s ability to continue as a going concern.   Management’s plans include the continued commercialization of the Company’s products and securing sufficient financing through the sale of additional equity securities, debt or capital inflows from strategic partnerships. Additional funds may not be available when the Company needs them, on terms that are acceptable to it, or at all. If the Company is unsuccessful in commercializing its products and securing sufficient financing, it may need to cease operations.   The financial statements include no adjustments for measurement or presentation of assets and liabilities, which may be required should the Company fail to operate as a going concern.         c. In October 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched extensive rocket attacks on the Israeli population and industrial centers located along Israel’s border with the Gaza Strip and in other areas within the State of Israel. These attacks resulted in thousands of deaths and injuries, and Hamas additionally kidnapped many Israeli civilians and soldiers. Following the attack, Israel’s security cabinet declared war against Hamas and commenced a military campaign against Hamas and other terrorist organizations in parallel to their continued rocket and terror attacks. In addition, since the commencement of these events, there have been continued hostilities along Israel’s northern border with Lebanon (with the Hezbollah terror organization) and southern border (with the Houthi movement in Yemen). It is possible that hostilities with Hezbollah in Lebanon will escalate, and that other terrorist organizations, including Palestinian military organizations in the West Bank as well as other hostile countries will join the hostilities. In addition, Iran recently launched a direct attack on Israel involving hundreds of drones and missiles and has threatened to continue to attack Israel and is widely believed to be developing nuclear weapons. Iran is also believed to have a strong influence among extremist groups in the region, such as Hamas in Gaza, Hezbollah in Lebanon, the Houthi movement in Yemen and various rebel militia groups in Syria and Iraq. Such clashes may escalate in the future into a greater regional conflict.           The war with Hamas has had an immaterial effect on its operations and financial results so far. This is attributable to its global footprint and the offices in Spain, which has become a hub for the Company’s sizing solutions business. The majority of Orgad’s inventory utilizes fulfillment by Amazon rather than fulfilling directly. Inventory is now maintained and orders are shipped from regional Amazon warehouses, thereby reducing exposure to inventory risk and contributing to operating efficiencies.   On February 24, 2022, Russia invaded Ukraine. The outbreak of hostilities between the two countries could result in more widespread conflict and could have a severe adverse effect on the region. Following Russia’s actions, various countries, issued broad-ranging economic sanctions against Russia. Such sanctions included, among other things, a prohibition on doing business with certain Russian companies, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications (SWIFT) electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions.   The Company shut down its operation in Russia and expected to close down its subsidiary, My Size LLC, but due to technical reasons it is expected to occur in the near future; therefore, the impact from the current situation is very limited.     MY SIZE, INC. AND ITS SUBSIDIARIES   Notes to Condensed Consolidated Interim Financial Statements (Unaudited) U.S. dollars in thousands (except share data and per share data)

Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2 - Significant Accounting Policies     a. Unaudited condensed consolidated financial statements:           The accompanying unaudited condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the rules and regulations of the United States Securities and Exchange Commission (“SEC”). The unaudited condensed consolidated financial statements are comprised of the financial statements of the Company. In management’s opinion, the interim financial data presented includes all adjustments necessary for a fair presentation. All intercompany accounts and transactions have been eliminated. Operating results for the six months ended June 30, 2024 are not necessarily indicative of the results that may be expected for any future period or for the year ending December 31, 2024.           These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2023.         b. Significant Accounting Policies:           The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the latest annual financial statements.         c. Critical accounting estimates:           ASC 350 requires goodwill to be tested for impairment at the reporting unit level at least annually, or between annual tests under certain circumstances, and written down when impaired. Goodwill is tested for impairment by comparing the fair value of the reporting unit with it carrying value.           During the first and second quarters of 2024, there was no more likely than not indication of impairment; therefore, no further impairment testing was required.         d. Recent adopted accounting pronouncements:           In June 2022, the FASB issued ASC 2022-03 “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”. The ASU clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring its fair value. The ASU also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The ASU also introduces new disclosure requirements for equity securities subject to contractual sale restrictions. The ASU do not have a material impact on the Company consolidated financial statements.           In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). This ASU reduces the number of accounting models for convertible debt instruments and convertible preferred stock and amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. In addition, this ASU improves and amends the related earnings per share guidance. This standard became effective for the Company beginning on January 1, 2024. Adoption is either a modified retrospective method or a fully retrospective method of transition. The Company adopted this guidance effective January 1, 2024, and the adoption of this standard did not have a material impact on its consolidated financial statements.

Financial Instruments	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Financial Instruments	Note 3 – Financial Instruments   The carrying amounts of cash and cash equivalents, restricted cash, accounts receivable, other receivables, trade payables and accounts payable approximate their fair value due to the short-term maturities of such instruments.   The Company holds share certificates in iMine Corporation (“iMine”), formerly known as Diamante Minerals, Inc., a publicly traded company on the OTCQB.   Due to sales restrictions on the sale of the iMine shares, the fair value of the shares was measured on the basis of the quoted market price for an otherwise identical unrestricted equity instrument of the same issuer that trades in a public market, adjusted to reflect the effect of the sales restrictions and is therefore, ranked as Level 2 assets.         June 30, 2024       Fair value hierarchy       Level 1     Level 2     Level 3   Financial assets                                             Investment in marketable securities (*)     -       10       -       MY SIZE, INC. AND ITS SUBSIDIARIES   Notes to Condensed Consolidated Interim Financial Statements (Unaudited) U.S. dollars in thousands (except share data and per share data)   Note 3 - Financial Instruments (Cont.)       December 31, 2023       Fair value hierarchy       Level 1     Level 2     Level 3   Financial assets                                             Investment in marketable securities (*)     -       6       -     (*) For the six and three-month periods ended June 30, 2024 and 2023, the Company recognized gain (loss) (based on quoted market prices with a discount due to security restrictions on iMine shares) of the marketable securities was $4, $(21), $(1) $and $(7), respectively.

Stock Based Compensation	6 Months Ended
	Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]
Stock Based Compensation	Note 4 - Stock Based Compensation   The stock-based expense equity awards recognized in the financial statements for services received is related to Cost of Revenues, Research and Development, Sales and Marketing and General and Administrative expenses as shown in the following table:       Six months ended June 30,     Three months ended June 30,       2024     2023     2024     2023                             Stock-based compensation expense – Cost of revenues     1       15       -       6   Stock-based compensation expense - Research and development     29       29       16       6   Stock-based compensation expense - Sales and marketing     24       55       8       15   Stock-based compensation expense - General and administrative     166       123       55       59                                         220       222       79       86       MY SIZE, INC. AND ITS SUBSIDIARIES   Notes to Condensed Consolidated Interim Financial Statements (Unaudited) U.S. dollars in thousands (except share data and per share data)   Note 4 - Stock Based Compensation (Cont.)   Stock Option Plan for Employees:   In March 2017, the Company adopted the My Size, Inc. 2017 Equity Incentive Plan (the “2017 Employee Plan”) pursuant to which the Company’s Board of Directors may grant stock options and other equity awards to officers and key employees. The total number of shares of common stock which may be granted to directors, officers, employees under this plan, is limited to 130,000 shares. Stock options can be granted with an exercise price equal to or less than the stock’s fair market value at the date of grant.   On December 27, 2023, the Company’s stockholders approved an increase in the shares available for issuance under the 2017 Equity Incentive Plan from 36,125 shares to 130,000 shares.   On February 14, 2024, the Compensation Committee of the Company granted restricted common stock awards under the Company’s 2017 Equity Incentive Plan to Ronen Luzon, Or Kles and Billy Pardo, pursuant to which they were issued 37,500 restricted shares, 18,750 restricted shares and 18,750 restricted shares, respectively. The restricted shares shall vest in three equal installments on January 1, 2025, January 1, 2026 and January 1, 2027, conditioned upon continuous employment with the Company and subject to accelerated vesting upon a change in control of the Company. On the same day, the Company granted a total of 10,000 restricted stock units (“RSUs”) to its directors that will vest on January 1, 2025 and five-years options to purchase up to 6,875 shares of common stock to other employees of the Company at an exercise price of $3.832 per share. The option vesting period is over three years in three equal portions from the vesting commencement date.   The fair value of each option award is estimated on the date of grant using the Binomial option-pricing model that used the weighted average assumptions in the following table. The risk free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant       2024 Grants   Dividend yield     0 % Expected volatility     86.22 % Risk-free interest     4.3 % Contractual term     2.0-2.8     During the six and three-month periods ended June 30, 2024, the Company granted options, restricted stock and RSUs to purchase 91,875 and 0 shares of common stock under the 2017 Employee Plan (as described above), respectively. No options were exercised and 4,000 options expired.   The total stock option compensation expense for employees during the six and three-month periods ended June 30, 2024 and 2023 was $146, $79, $162 and $44, respectively.   The total stock option compensation expense relating to the Orgad acquisition during the six and three-month periods ended June 30, 2024 and 2023 was $3, $0, $60 and $118, respectively.   Options issued to consultants:   In July 2023, the Company entered into a six month agreement (the “Consultant Agreement”) with a consultant (the “Consultant”) to provide services to the Company, including assisting the Company to promote, market and sell the Company’s technology to potential customers and make strategic introductions and inquiries with interested parties in the financial community. Pursuant to the Consultant Agreement and in partial consideration for such consulting services, the Company issued to the Consultant (i) 5,000 shares of restricted common stock of the Company, (ii) a warrant to purchase 12,500 shares of common stock at an exercise price of $4.00 per share and exercisable for a term of 36 months from the date of issuance, and (iii) a warrant to purchase 12,500 shares of common stock at an exercise price of $6.00 per share and exercisable for a term of 36 months from the date of issuance.   The issuance was approved by the Company’s board of directors in February 2024.   During the six and three-month periods ended June 30, 2024, the Company recorded $71 and $0, respectively, as stock-based equity awards with respect to the Consultant. No expenses were recorded in the fiscal year ended December 31, 2023 with respect to the Consultant.     MY SIZE, INC. AND ITS SUBSIDIARIES   Notes to Condensed Consolidated Interim Financial Statements (Unaudited) U.S. dollars in thousands (except share data and per share data)

Contingencies and Commitments	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Contingencies and Commitments	Note 5 - Contingencies and Commitments     a. On August 7, 2018, the Company commenced an action against North Empire LLC (“North Empire”) in the Supreme Court of the State of New York, County of New York for breach of a Securities Purchase Agreement (the “Agreement”) in which it is seeking damages in an amount to be determined at trial, but in no event less than $616. On August 2, 2018, North Empire filed a Summons with Notice against the Company, also in the same Court, in which they allege damages in an amount of $11,400 arising from an alleged breach of the Agreement. On September 6, 2018 North Empire filed a Notice of Discontinuance of the action it had filed on August 2, 2018. On September 27, 2018, North Empire filed an answer and asserted counterclaims in the action commenced by the Company against them, alleging that the Company failed to deliver stock certificates to North Empire causing damage to North Empire in the amount of $10,958. North Empire also filed a third-party complaint against the Company’s CEO and now former Chairman of the Board asserting similar claims against them in their individual capacities. On October 17, 2018, the Company filed a reply to North Empire’s counterclaims. On November 15, 2018, the Company’s CEO and now former Chairman of the Board filed a motion to dismiss North Empire’s third-party complaint. On January 6, 2020, the Court granted the motion and dismissed the third-party complaint. Discovery has been completed and both parties have filed motions for summary judgment in connection with the claims and counterclaims. On December 30, 2021, the Court denied both the Company and North Empire’s motions for summary judgment, arguing there were factual issues to be determined at trial. On January 26, 2022, the Company filed a notice of appeal of the summary judgment decision. On February 3, 2022, the Company filed a motion to reargue the Court’s decision denying the Company’s motion for summary judgment. North Empire will file its opposition papers on or before March 31, 2022, and the Company will file reply papers on April 29, 2022. On or about September 12, 2022, the Court issued its Decision and Order denying the Company’s motion to reargue. North Empire filed its opposing brief on December 7, 2022. Both sides were given an opportunity to file a reply brief. The Company filed a reply brief on January 4, 2023 and North Empire filed its reply brief on January 13, 2023. The Appellate Court has scheduled oral argument for the appeal for February 7, 2023. Oral argument was held before the Appellate Court on February 7, 2023. On or about February 28, 2023, the Appellate Court filed its Decision and Order, which affirmed the lower court’s decisions regarding both the Company and North Empire’s motions for summary judgment and sent the case back to the Supreme Court. On March 13, 2023, the Supreme Court referred the case to its Alternative Dispute Program and ordered the cases to mediate. The mediation was held on July 26, 2023 and various settlement options were explored but the mediation did not lead to settlement. On December 21, 2023, a conference with the Court was held and the parties were given dates for various pre-trial filings. The parties are exploring a resolution and the Court has adjourned the pre-trial deadlines. On July 30, 2024, the parties provided the Court with a status update regarding a possible resolution of the action. As such, the Court has instructed the parties to provide a further update on August 13, 2024. The Company intends to vigorously defend any claims made by North Empire. The Company believes it is more likely than not that the counterclaims will be denied.         b. In July 2024, the Company was served with a legal complaint filed by Shimon Shukron in the Magistrate’s Court in Herzliya for a monetary award in an amount of NIS 1,895,345 (approximately $510). The plaintiff alleges that due to the fire that broke out at Orgad’s warehouse in January 2023, the fire spread to the plaintiff’s business and caused heavy damage to the structure and contents, inventory of the business and loss of profits. The Company plans to file its statement of defense in September 2024. At this preliminary stage, before any fact finding and pre-trial procedures (including disclosure of documents) have been conducted and before the statement of defense has been prepared and filed, the Company cannot evaluate the chances of the claim to succeed.

Goodwill	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Note 6 - Goodwill   During the third quarter of 2023, the Company merged its two software-as-a-service (“SaaS”) segments into one segment (see Note 7), which also resulted in a change in the Company’s composition of reporting units. In the Company’s financial reporting for June 30, 2024, comparative information for 2023 was restated to reflect the changes in reportable segments.   After the restructuring, the aggregate carrying amounts of goodwill allocated to each reporting unit are as follows:       June 30       2024     2023   SaaS Solutions     603       1,271   Fashion and equipment e-commerce platform     130       132       733       1,403       MY SIZE, INC. AND ITS SUBSIDIARIES   Notes to Condensed Consolidated Interim Financial Statements (Unaudited) U.S. dollars in thousands (except share data and per share data)

Operating Segments	6 Months Ended
	Jun. 30, 2024
Segment Reporting [Abstract]
Operating Segments	Note 7 – Operating Segments   Effective July 1, 2023 the Company merged its two SaaS segments into one segment, reducing its reportable segments from three to the following two segments: (i) fashion and equipment e-commerce platform, and (ii) SaaS based innovative artificial intelligence driven measurement solutions. This realignment reflects the way resources are allocated and performance is assessed by the Chief Operating Decision Maker. The fashion and equipment e-commerce platform which represents Orgad’s activity that was acquired by the Company in 2022, mainly operates on Amazon. The SaaS based innovative artificial intelligence driven measurement solutions, or SaaS Solutions operating segment consists of My Size Inc., My Size Israel, My Size LLC and Naiz Fit.   In the Company’s financial reporting for six and three-month periods ended June 30, 2024, comparative information for 2023 was restated to reflect the changes in reportable segments.   Information related to the operations of the Company’s reportable operating segments is set forth below:       Fashion and equipment e-commerce platform     SaaS Solutions     Total   As of the six months ended June 30, 2024                         Revenues from external customers     4,623       340       4,963   Operating loss     (1,042 )     (906 )     (1,948 )       Fashion and equipment e-commerce platform       Saas Solution   As of June 30, 2024:     5,672       2,340   Assets                       Fashion and equipment e-commerce platform     SaaS Solutions     Total   As of the six months ended June 30, 2023                         Revenues from external customers     1,738       272       2,010   Operating loss     (2,495 )     (1,551 )     (4,046 )     MY SIZE, INC. AND ITS SUBSIDIARIES   Notes to Condensed Consolidated Interim Financial Statements (Unaudited) U.S. dollars in thousands (except share data and per share data)   Note 7 – Operating Segments (Cont.)       Fashion and equipment e-commerce platform     SaaS Solutions     Total   As of the three months ended June 30, 2024                         Revenues from external customers     1,816       163       1,979   Operating loss     (460 )     (417 )     (877 )       Fashion and equipment e-commerce platform     SaaS Solutions     Total   As of the three months ended June 30, 2023                         Revenues from external customers     1,160       130       1,290   Operating loss     (818 )     (736 )     (1,554 )       Fashion and equipment e-commerce platform     SaaS Solutions     Total   As of the year ended December 31, 2023                         Revenues from external customers     6,367       629       6,996   Operating loss     (3,356 )     (3,385 )     (6,741 )       Fashion and equipment e-commerce platform       SaaS Solutions   As of December 31, 2023:                 Assets     6,352       2,639       MY SIZE, INC. AND ITS SUBSIDIARIES   Notes to Condensed Consolidated Interim Financial Statements (Unaudited) U.S. dollars in thousands (except share data and per share data)

Significant events during the reporting period	6 Months Ended
	Jun. 30, 2024
Significant Events During Reporting Period
Significant events during the reporting period	Note 8 – Significant events during the reporting period     a. Further to note 16 to the Company’s 10-K for the year ended December 31, 2023, which was filed with the SEC on April 1, 2024, the Company agreed to pay to the former owners of Orgad on the two-year and the three-year anniversary anniversaries of the closing of the transaction pursuant to which the Company acquired 100% of the shares and voting interests in Orgad, $350 in each of these years, provided that in the case of the second and third instalments certain revenue targets are met and subject further to certain downward post-closing adjustment. In February 2024, the amount of $700 was fully paid to the former owners of Orgad net of a settlement amount of $275.     b. On January 8, 2024, the Company provided a notice of six month termination to the lessor that the office lease agreement will end on July 8, 2024 instead of August 20, 2025.           As a result the Company reduced its “Right of use asset” against current liabilities as “Operating lease liability” and in the non-current liabilities as “Operating lease liability – long term” on the Company’s June 30, 2024 consolidated balance sheets in an amount of $181.         c. During February 2024, the Company received a loan from a commercial lender in an amount of $500. The loan bears interest at a fix rate of 6% of the principal and payable in installments during six month term.     d. On April 19, 2024, the Company effected a one-for-eight reverse stock split of its common stock (the “Reverse Stock Split”) with the Company’s shares beginning trading on a post-split basis on the Nasdaq Capital Market on April 23, 2024. Upon the Reverse Stock Split, every eight shares of the Company’s issued and outstanding common stock was automatically converted into one share of common stock, without any change in the par value per share. In addition, a proportionate adjustment was made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding options and warrants entitling the holders to purchase common stock. Any fraction of a share of common stock that would otherwise have resulted from the Reverse Stock Split was rounded up to the next whole number.         e. On November 3, 2023, the Company was notified, by the Nasdaq Listing Qualifications that the Company is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on the Nasdaq. The Notification Letter provided that the Company had 180 calendar days, or until May 1, 2024, to regain compliance with the Rule. To regain compliance, the bid price of the Company’s common stock must have had a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. On May 7, 2024, the Company received a letter from Nasdaq that, for the 10 consecutive business days from April 23, 2024 to May 6, 2024, the closing bid price of the Company’s common stock had been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the prior bid price deficiency matter now closed.         f. On May 16, 2024, the Company entered into an inducement offer letter agreement (the “Inducement Letter”) with a certain holder (the “Holder”) of certain of the Company’s existing warrants to purchase up to (i) 326,514 shares of the Company’s common stock issued on August 28, 2023 with a twenty-eight month term at an exercise price of $16.72 per share and (ii) 344,475 shares of the Company’s common stock issued on August 28, 2023 with a five and one-half year term at an exercise price of $16.72 per share, ((i) and (ii) collectively, the “Existing Warrants).   Pursuant to the Inducement Letter, the Holder agreed to exercise for cash its Existing Warrants to purchase an aggregate of 670,989 shares of the Company’s common stock at a reduced exercise price of $4.86 per share in consideration of the Company’s agreement to issue new common stock purchase warrants (the “New Warrants”) to purchase up to an aggregate of 1,341,978 shares of the Company’s common stock, at an exercise price of $4.61 per share. The Company received aggregate gross proceeds of approximately $3.26 million from the exercise of the Existing Warrants by the Holder, before deducting placement agent fees and other offering expenses payable by the Company. As of June 30, 2024, the Company issued to the Holder 166,989 of the shares exercised with the remaining  504,000 share held  in abeyance.   The Company engaged H.C. Wainwright & Co., LLC (the “Placement Agent”) to act as its exclusive placement agent in connection with the transactions contemplated by the Inducement Letter and paid the Placement Agent a cash fee equal to 7.0% of the aggregate gross proceeds received from the Holder’s exercise of the Existing Warrants, as well as a management fee equal to 1.0% of the gross proceeds from the exercise of the Existing Warrants. Upon exercise for cash of any New Warrants, the Company has agreed in certain circumstances to pay the Placement Agent a cash fee of 7.0% of the aggregate gross exercise price paid in cash with respect the exercise of the New Warrants, and a management fee of 1.0 % of the aggregate gross exercise price paid in cash with respect to the New Warrants. The Company also issued to the Placement Agent or its designees warrants (the “Placement Agent Warrants”) to purchase up to 46,969 shares of common stock (representing 7.0% of the Existing Warrants being exercised), which have the same terms as the New Warrants except the Placement Agent Warrants have an exercise price equal to $6.075 per share (125% of the reduced exercise price of the Existing Warrants). Similar to the New Warrants, the Placement Agent Warrants were immediately exercisable from the date of issuance until the five and one-half year anniversary of such date. In addition, the Company paid the Placement Agent up to $85 for non-accountable expenses and other out-of-pocket expenses and $16 for clearing fees.

Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Significant Assets and Liabilities Measured at Fair Value on Recurring Basis	June 30, 2024       Fair value hierarchy       Level 1     Level 2     Level 3   Financial assets                                             Investment in marketable securities (*)     -       10       -       MY SIZE, INC. AND ITS SUBSIDIARIES   Notes to Condensed Consolidated Interim Financial Statements (Unaudited) U.S. dollars in thousands (except share data and per share data)   Note 3 - Financial Instruments (Cont.)       December 31, 2023       Fair value hierarchy       Level 1     Level 2     Level 3   Financial assets                                             Investment in marketable securities (*)     -       6       -     (*) For the six and three-month periods ended June 30, 2024 and 2023, the Company recognized gain (loss) (based on quoted market prices with a discount due to security restrictions on iMine shares) of the marketable securities was $4, $(21), $(1) $and $(7), respectively.

Stock Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2024
Schedule of Stock Based Compensation Expenses	The stock-based expense equity awards recognized in the financial statements for services received is related to Cost of Revenues, Research and Development, Sales and Marketing and General and Administrative expenses as shown in the following table:       Six months ended June 30,     Three months ended June 30,       2024     2023     2024     2023                             Stock-based compensation expense – Cost of revenues     1       15       -       6   Stock-based compensation expense - Research and development     29       29       16       6   Stock-based compensation expense - Sales and marketing     24       55       8       15   Stock-based compensation expense - General and administrative     166       123       55       59                                         220       222       79       86
Stock Option Plan For Employees [Member]
Schedule of Fair Value Assumptions of Stock Option	2024 Grants   Dividend yield     0 % Expected volatility     86.22 % Risk-free interest     4.3 % Contractual term     2.0-2.8

Goodwill (Tables)	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Aggregate Carrying Amount Of Goodwill	June 30       2024     2023   SaaS Solutions     603       1,271   Fashion and equipment e-commerce platform     130       132       733       1,403

Operating Segments (Tables)	6 Months Ended
	Jun. 30, 2024
Segment Reporting [Abstract]
Schedule of Reportable Operating Segments	Information related to the operations of the Company’s reportable operating segments is set forth below:       Fashion and equipment e-commerce platform     SaaS Solutions     Total   As of the six months ended June 30, 2024                         Revenues from external customers     4,623       340       4,963   Operating loss     (1,042 )     (906 )     (1,948 )       Fashion and equipment e-commerce platform       Saas Solution   As of June 30, 2024:     5,672       2,340   Assets                       Fashion and equipment e-commerce platform     SaaS Solutions     Total   As of the six months ended June 30, 2023                         Revenues from external customers     1,738       272       2,010   Operating loss     (2,495 )     (1,551 )     (4,046 )     MY SIZE, INC. AND ITS SUBSIDIARIES   Notes to Condensed Consolidated Interim Financial Statements (Unaudited) U.S. dollars in thousands (except share data and per share data)   Note 7 – Operating Segments (Cont.)       Fashion and equipment e-commerce platform     SaaS Solutions     Total   As of the three months ended June 30, 2024                         Revenues from external customers     1,816       163       1,979   Operating loss     (460 )     (417 )     (877 )       Fashion and equipment e-commerce platform     SaaS Solutions     Total   As of the three months ended June 30, 2023                         Revenues from external customers     1,160       130       1,290   Operating loss     (818 )     (736 )     (1,554 )       Fashion and equipment e-commerce platform     SaaS Solutions     Total   As of the year ended December 31, 2023                         Revenues from external customers     6,367       629       6,996   Operating loss     (3,356 )     (3,385 )     (6,741 )       Fashion and equipment e-commerce platform       SaaS Solutions   As of December 31, 2023:                 Assets     6,352       2,639

General (Details Narrative) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 61,861	$ 59,881

Schedule of Significant Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands		Jun. 30, 2024	Dec. 31, 2023
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in marketable securities	[1]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in marketable securities	[1]	10	6
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in marketable securities	[1]
[1] For the six and three-month periods ended June 30, 2024 and 2023, the Company recognized gain (loss) (based on quoted market prices with a discount due to security restrictions on iMine shares) of the marketable securities was $4, $(21), $(1) $and $(7), respectively.

Schedule of Significant Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Realized gain (loss) on marketable securities	$ 21	$ 7	$ 4	$ 1

Schedule of Stock Based Compensation Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 79	$ 86	$ 220	$ 222
Cost of Revenues [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense		6	1	15
Research and Development Expense [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	16	6	29	29
Selling and Marketing Expense [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	8	15	24	55
General and Administrative Expense [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 55	$ 59	$ 166	$ 123

Schedule of Fair Value Assumptions of Stock Option (Details) - Employees [Member]	6 Months Ended
	Jun. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Dividend yield	0.00%
Expected volatility	86.22%
Risk-free interest	4.30%
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Contractual term	2 years
Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Contractual term	2 years 9 months 18 days

Stock Based Compensation (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Feb. 14, 2024	Jul. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 27, 2023	Dec. 26, 2023	Mar. 31, 2017
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Option description		(i) 5,000 shares of restricted common stock of the Company, (ii) a warrant to purchase 12,500 shares of common stock at an exercise price of $4.00 per share and exercisable for a term of 36 months from the date of issuance, and (iii) a warrant to purchase 12,500 shares of common stock at an exercise price of $6.00 per share and exercisable for a term of 36 months from the date of issuance
Orgad Acquisition [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock based compensation			$ 0	$ 118,000	$ 3,000	$ 60,000
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock based compensation			79,000	$ 44,000	146,000	$ 162,000
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted stock units granted	10,000
Consultant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock based compensation			$ 0		$ 71,000		$ 0
2017 Employee Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options granted										130,000
Restricted stock units granted			91,875		0
Number of stock options exercised			4,000		4,000
2017 Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Issuance of shares								130,000	36,125
Restricted stock units granted	6,875
Options term	5 years
Options exercise price	$ 3.832
2017 Equity Incentive Plan [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options term	5 years
2017 Equity Incentive Plan [Member] | Ronen Luzon [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted shares	37,500
2017 Equity Incentive Plan [Member] | OrKles [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted shares	18,750
2017 Equity Incentive Plan [Member] | Billy Pardo [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted shares	18,750

Contingencies and Commitments (Details Narrative) ₪ in Thousands, $ in Thousands				1 Months Ended
	Sep. 27, 2018 USD ($)	Aug. 07, 2018 USD ($)	Aug. 02, 2018 USD ($)	Jul. 31, 2024 USD ($)	Jul. 31, 2024 ILS (₪)
Shimon Shukron [Member] | Subsequent Event [Member]
Loss contingency, damages sought, value				$ 510	₪ 1,895,345
North Empire LLC [Member]
Loss contingency, damages sought, value	$ 10,958	$ 616	$ 11,400

Schedule of Aggregate Carrying Amount Of Goodwill (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023
Goodwill [Line Items]
Total	$ 733	$ 758	$ 1,403
Saas Solutions [Member]
Goodwill [Line Items]
Total	603		1,271
Fashion and Equipment E Commerce [Member]
Goodwill [Line Items]
Total	$ 130		$ 132

Schedule of Reportable Operating Segments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Segment Reporting Information [Line Items]
Revenues from external customers	$ 1,979	$ 1,290	$ 4,963	$ 2,010
Assets	8,012		8,012		$ 8,991
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues from external customers	1,979	1,290	4,963	2,010	6,996
Operating loss	(877)	(1,554)	(1,948)	(4,046)	(6,741)
Operating Segments [Member] | Fashion and Equipment ECommerce Platform [Member]
Segment Reporting Information [Line Items]
Revenues from external customers	1,816	1,160	4,623	1,738	6,367
Operating loss	(460)	(818)	(1,042)	(2,495)	(3,356)
Assets	5,672		5,672		6,352
Operating Segments [Member] | Saas Solutions [Member]
Segment Reporting Information [Line Items]
Revenues from external customers	163	130	340	272	629
Operating loss	(417)	$ (736)	(906)	$ (1,551)	(3,385)
Assets	$ 2,340		$ 2,340		$ 2,639

Operating Segments (Details Narrative) - Segment	Jul. 01, 2023	Jun. 30, 2023
Segment Reporting [Abstract]
Number of reportable segments	2	3

Significant events during the reporting period (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands				1 Months Ended	6 Months Ended
	May 16, 2024	Nov. 03, 2023	Aug. 28, 2023	Feb. 28, 2024	Jun. 30, 2024	Dec. 31, 2023
Operating lease liability					$ 15	$ 129
Sale of stock, description of transaction		The Notification Letter provided that the Company had 180 calendar days, or until May 1, 2024, to regain compliance with the Rule. To regain compliance, the bid price of the Company’s common stock must have had a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. On May 7, 2024, the Company received a letter from Nasdaq that, for the 10 consecutive business days from April 23, 2024 to May 6, 2024, the closing bid price of the Company’s common stock had been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the prior bid price deficiency matter now closed
Aggregate shares of common stock	46,969
Proceeds from Warrant Exercises	$ 3,260
Shares issued					166,989
Cash fee percentage	7.00%
Management fee percentage	1.00%
Fee percentage	125.00%
Other Expenses	$ 85
Clearance Fees	$ 16
Minimum [Member]
Exercise price per Share	$ 6.075
Warrant [Member]
Aggregate shares of common stock			326,514
Exercise price per Share			$ 16.72
Stock issued during period, shares, new issues			344,475
Warrant [Member] | Minimum [Member]
Aggregate shares of common stock	670,989
Exercise price per Share	$ 4.86
Warrant [Member] | Maximum [Member]
Aggregate shares of common stock	1,341,978
Exercise price per Share	$ 4.61
Abeyance [Member]
Remaining shares outstanding					504,000
Orgad [Member] | Second and Third Instalments [Member]
Revenue recognition milestone percentage					100.00%
Revenue recognition milestone amount					$ 350
Paid to former owners				$ 700
Settlement amount				$ 275
Operating lease liability					181
Loan received from commercial lender					$ 500
Interest percentage					6.00%

---